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ABSTRACT
The primary focus of my research was to obtain global gene expression profiles of baker’s yeast
exposed to sub-lethal doses of nanoparticles, such as silver nanoparticles (AgNPs), yellowemitting CdSe/ZnS quantum dots (QDs), green-emitting CdSe/ZnS QDs, and InP/ZnS QDs, to
reveal novel insights on their unique mechanisms of toxicity. Despite their diverse applications,
their long-lasting effects on the environment and human health are not well understood. To
assess their toxicity, I administered experiments that exposed Saccharomyces cerevisiae to a
variety of nanoparticles and measured cell viability, ROS levels, and changes in gene expression.
Most notably, I used RNA-sequencing (RNA-seq) to identify gene identities of differentially
expressed genes (DEGs) in nanoparticle-treated cultures. I found AgNPs altered genes
implicated in rRNA processing, ribosome biogenesis, cell wall/cell membrane structure, and
mitochondrial functions, yellow-emitting CdSe/ZnS QDs altered genes implicated in RNA
processing, translation, oxidation-reduction, transmembrane-transport, and the ETC, greenemitting QDs altered genes implicated in translation, protein metabolic processes,
transmembrane transport, cellular homeostasis, and cell wall organization, and InP/ZnS QDs
altered genes associated with oxidation-reduction, transmembrane-transport, metal ion
homeostasis, translation, and protein compound metabolic processes. Nevertheless, I concluded
that all tested nanoparticles exerted some sort of cytotoxic effect by disrupting normal cellular
functions of the budding yeast.

KEYWORDS: AgNPs, CdSe/ZnS, InP/ZnS, QDs, gene expression, RNA-seq, DEGs,
Saccharomyces cerevisiae
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CHAPTER 1: A REVIEW ON TRANSCRIPTOME PROFILE ALTERATIONS WITH
CARBON NANOTUBES, QUANTUM DOTS, AND SILVER NANOPARTICLES

Introduction
Sequence based high-throughput research is quickly becoming the preferred choice in
gene expression studies. These technologies are extremely sensitive and capable of wholetranscriptome sequencing and can determine the presence of and quantity levels of RNA. The
most accurate technique, RNA-seq, has been around for more than a decade and can detect the
slightest changes in gene expression with unprecedented accuracy [1]. It is quickly surpassing
older technological sequencing methods, including microarray, in gene expression studies. RNAseq has been shown to provide gene expression measurements with greater quantitative and
qualitative information and with greater accuracy than the microarray method. Furthermore,
RNA-seq technology coupled with bioinformatics tools has been shown to be the superior
approach in studying global gene expression dynamics in practically all biological settings.
Despite the numerous advantages of gene expression-based methods, these sequencing
technologies still face statistical and computational challenges due to the limited availability of
reliable software programs with large computational and storage capabilities.
In recent years, high-throughput sequencing has become more popular in studying the
toxicity of chemical agents, including Engineered Nano Materials (ENMs), through observable
changes in transcript levels. While steadily gaining popularity, these modern genomic
approaches, used for studying the impacts of ENM-toxicity on living systems, remain infrequent
in modern studies. ENMs are implemented in numerous commercial and industrial sectors due to
their extremely small size ranges of 1-100 nm [2]. ENM-toxicity is an enormous area of research
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that has adopted the microarray and, newer, RNA-seq methods. They have primarily been used
to investigate the toxicity of ENMs through identifying similar changes in global gene
expression among different cell types and organisms. Since their discovery, our understanding of
nanotechnologies has broadened resulting in novel and innovative medical and commercial
applications. ENMs have attracted attention from nearly every industry due to their promising
potential applications in chemical, catalytic, electronic, optical, mechanical, magnetic, and
medical fields. For instance, some of their applications are due to their capacity to diagnosis and
treat a considerable number of human diseases [2]. Even so, there is still much we do not
understand regarding their potential toxicity. If we want to continue to use these
nanotechnologies responsibly, we must conduct more research to identify their unpredictable,
and potentially negative, effects on our health and the environment.
ENMs have a lot of diversity, and there are many different classes, including single and
multi-walled carbon nanotubes, gold and silver nanoparticles, fullerenes, dendrimers, metal
oxides, quantum dots, and many more [3, 4]. There is even greater diversity in their
physiochemical properties, which are believed to contribute to their toxicity, and which make it
exceedingly difficult to characterize their mechanisms by which they induce toxicity. To make
things even more challenging, it is possible that the physiochemical properties of ENMs change
after interacting with bio-molecules [4]. Furthermore, findings on ENM toxicology can vary
drastically among extremely similar ENMs with almost identical physiochemical properties.
These setbacks present the field with enormously challenging limitations in creating regulatory
methods of determining ENM toxicity. In this review, I attempt to examine the toxicity of three
ENMs including carbon nanotubes (CNTs), quantum dots (QDs), and Ag nanoparticles (AgNPs)
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by highlighting and cross-examining their effects on global gene expression profiles in multiple
cellular and higher organism models.

Materials and Methods
AgNPs. 20 nm PELCO®NanoXact™ silver nanoparticle (AgNPs), suspended in a
concentration of 20 µg/mL in 2 mM sodium citrate solution (pH 7.6), was obtained from Ted
Pella, Inc (Redding, CA, USA). The average diameter of the spheroidal nanoparticles (NPs) was
20 ± 2.9 nm, measured by JOEL 1010 transmission electron microscope (for more chemical and
physical information, visit: www.nanocomposix.com). This sample of NPs showed the
absorption band at 393 nm (www.nanocomposix.com).
Yellow-Emitting CdSe/ZnS QDs. Yellow-emitting CdSe/ZnS QDs (catalog number
CZW-Y) with an emission color of yellow and a carboxylic acid stabilizing ligand with <1%
organic impurities (not including ligands), suspended in water (1000 μg/mL), were obtained
from NN-Labs (Fayetteville, AR, USA). The ZnS shell around the CdSe-QD core protects and
stabilizes the QD’s unique optical properties while maintaining the same absorption (estimated
550–600 nm) and emission (570–585 nm) properties of the core. NN-Labs did not provide the
size of their yellow CdSe/ZnS-QDs, and the size was not available on the NN-Labs website.
Baig et al. and associates, via transmission electron microscopy (TEM), determined the sizes of
CdSe/ZnS-QDs with emission colors of green, yellow, and red to be 3.0, 4.1, and 5.5 nm,
respectively [5]. These results led us to assume the size of the yellow CdSe/ZnS-QDs to be
approximately 4.1 nm.
Green-Emitting CdSe/ZnS and InP/ZnS QDs. Green CdSe/ZnS and InP/ZnS QDs with
functionalized carboxylic acid ligands were suspended in water at a concentration of 1000
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μg/mL. They were obtained from NN-Labs (Fayetteville, AR, USA). CdSe- and InP-QD cores
were capped with ZnS-shells to stabilize their absorption and emission wavelengths. The
core/shell nanocrystal structure demonstrates brighter fluorescence and increased control over
the surface chemistry. The emission wavelength of green-emitting CdSe/ZnS QDs were found to
be 530–550 nm [6] and InP/ZnS QDs 530 nm +/−15 nm (NNCrystal US Corporation,
Fayetteville, AR, USA) (unpublished). The size of the 530 nm CdSe/ZnS QDs were found to be
6.1–9.5 nm [6] and the 530 nm InP/ZnS QDs were found to be 3.2–4.2 nm in diameter [7]. QD
size was verified using a JEOL 7900F scanning electron microscope (SEM, JOEL, Peabody,
USA) with a scanning transmission electron microscopy (STEM) detector to image individual
QDs, and the results were in agreement with datasheet values provided by the NNCrystal US
Corporation website (nn-labs.com, January 2021) [6, 7].
Growth Assay with Exposure to AgNPs, CdSe/ZnS, and InP/ZnS. Wild
type Saccharomyces cerevisiae cells (S288C) were purchased from ATCC (American Type
Culture Collection, Manassas, VA, USA) and cultured in synthetic defined glucose (SDGlucose) media overnight in a shaking incubator (INFORS HT Minitron) at 30 °C. The optical
density (OD) was recorded at 600 nm with a BioMateTM 3S spectrophotometer (Thermo
Scientific, Waltham, MA, USA). The cells were cultured for 16–18 h in the shaking incubator to
a minimum concentration of 1 × 107 cells/mL. After confirming the OD was adequate, the cells
were inoculated into a 2x SD-Glucose media stock to an OD of 0.1. The newly made stock of
cells was plated on a 96-well culture plate following the plating of AgNPs at concentrations of
0.05, 0.1, 0.5, 1, 2, 5 and 10 μg/mL (Figure 1), yellow-emitting CdSe/ZnS QDs at concentrations
of 0, 0.8, 1.6, 3.15, 6.25, 12.5, 25, 50, and 100 μg/mL (Chapter III), green-emitting CdSe/ZnS
QDs at concentrations of 0, 10, 20, 50, and 100 μg/mL (Chapter IV), and InP/ZnS QDs at
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concentrations of 0, 1, 10, 50, and 100 μg/mL (Chapter IV). Upon completion of plating QDs
and cells, the 96-well plate was inserted into an ELx808TM absorbance microplate reader (Biotek,
Winooski, VT, USA) and grown, while shaken fast, for 24 h at 30 °C. Simultaneously, the plate
reader recorded the OD every 30 minutes at a wavelength of 594 nm. Blank well ODs (media +
nanoparticles without cells) were subtracted from nanoparticle-treated wells (with cells) and
averaged to create growth curves that represented all eight test concentrations, and were then
compared to the NTC growth curves. The log section of the growth curves was used to calculate
doubling times for each treatment group. The growth curve assay was conducted in triplicate.
Metabolic Activity Assessment using FUN-1 Dye (Chapter II). FUN-1 cell stain dye, a
viability probe for fungal cells, was purchased from Thermo Fisher Scientific. Yeast cells
(S288C) were grown for 16–18 h to an OD of 1.0 in SD-Glu media. The following day second
inoculation was made and once again grown for 16– 18 h to an OD of 1.0. The cells were then
inoculated into SD-Glu media to an OD of 0.2 with an AgNP concentration of 0, 5 or 10 μg/mL
and were grown for 5 h at 30◦C in a shaker incubator. The cells were spun and transferred to 0.2
μm filtered water containing 2% D-glucose and 10 mM Na-HEPES and stained using 1 μL of 10
mM FUN-1 stock solution (final concentration of 20 μM) for 30 min. Stained cells were then
examined using an Olympus IX81 inverted fluorescent microscope equipped with an ORCA
camera (Hamamatsu, Bridgewater, NJ) with the excitation/emission filter set at 480/620 nm.
Total RNA Extraction. Yeast cells (S288C) were grown in SD-Glu media to mid-log
phase corresponding to an OD at 600 nm of 0.3–0.6. These cells were incubated at 30◦C with
shaking at 220 rpm with either SD-Glu media only for the control or SD-Glu media containing 5
μg/mL of AgNPs for 5 h. These experiments were performed in triplicates. Total RNA was
extracted with the protocol and materials from RiboPure Yeast RNA Extraction Kit (Thermo
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Fisher Scientific) on three control, three AgNP-treated (Chapter II), three yellow-emitting
CdSe/ZnS QD-treated (Chapter III), green-emitting CdSe/ZnS QDs (Chapter IV), and InP/ZnS
QDs (Chapter IV). The RNA concentration was calculated by measuring the OD at 280 nm using
NanoPhotometerR P330 (v1.0, Implen, Westlake Village, CA) or the Qubit 3.0 Fluorometer.
Final concentrations of total RNA ranged from 960 to 1200 ng/μL.
mRNA Isolation and cDNA Synthesis (Chapters II and III). mRNA was isolated from
the total RNA, using TruSeqR Stranded mRNA LT Sample Preparation Kit (Illumina, San
Diego, CA) by following the Low Sample Protocol. The first strands of cDNA were synthesized
from the purified mRNA, using SuperScript II Reverse Transcriptase from the kit, followed by
synthesis of the second strand of cDNA. Each cDNA sample was ligated with a distinct adaptor
for sequencing, and the ligated cDNA fragments on both ends were amplified for 15 cycles. The
end products were suspended in 30 μL Resuspension Buffer with final concentrations ranging
from 45 to 60 ng/μL. The enriched cDNA libraries were sequenced using an Illumina hiseq 2500
Sequencing system (Kansas Medical Genome Center). One hundred nucleotides from only one
end of each sequence (single-end sequencing) were completed with the cDNA libraries
originated from three control, three AgNP-treated, and yellow-emitting CdSe/ZnS cells.
mRNA Isolation and cDNA Synthesis (Chapter IV). Yeast cells (S288C) were grown
in SD-Glu media to mid-log phase corresponding to an OD at 600 nm of 0.3–0.6. These cells
were incubated at 30 °C and shaken at 220 rpm for 5 h. This experiment was performed in
triplicate consisting of three control samples (containing only SD-Glucose media and cells),
three samples treated with green-emitting CdSe/ZnS QDs (10 μg/mL), and three samples treated
with InP/ZnS QDs (100 μg/mL). The RiboPure Yeast RNA Extraction Kit (Thermo Fisher
Scientific) was used on all control and QD-treated samples. The RNA concentrations were
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measured with a Qubit 3.0 Fluorometer (ThermoFisher, Waltham, MA, USA) and fell within the
acceptable range of 10 ng to 1 μg for library amplification. The Universal Plus mRNA-Seq Kit
(NuGEN, Reddwood City, CA, USA) was used to generate adaptor-ligated sequencing-ready
cDNA libraries from treated and non-treated total RNA samples. cDNA libraries were sequenced
using an Illumina HiSeq 2500 Sequencing system (Kansas Medical Genome Center, Kansas
City, MO, USA). One hundred nucleotides from only one end of each sequence (double-end
sequencing) were completed with the cDNA libraries originated from three control, three
CdSe/ZnS QD treated, and three InP/ZnS QD treated cells.
Analysis of Sequencing Data. Data from cDNA sequencing were analyzed using
Galaxy, a website platform for analyzing sequenced data (www.usegalaxy.org). The data
obtained from the Kansas Medical Genome Center was uploaded to the Galaxy server, where
sequences that were separated, when sent to us, were concatenated back together so the full reads
could be analyzed. A quality check was carried out on each file of sequence data to check the
quality of the reads and ensure good samples and that the data is interpreted correctly. The files
were then re-formatted into Sanger, which is necessary for the steps to follow. To achieve high
fidelity, the files were trimmed based on quality, and bases with a quality score below 20 were
removed from the reads. For eliminating the bias of primers and to ensure the removal of
adapters, 12 bases were trimmed from the 5′ end of the reads. The remaining reads were then
filtered to remove any reads less than 80 base pairs. Next, reads were aligned to the wild
type Saccharomyces cerevisiae reference genome (S288C) obtained from the Saccharomyces
genome database (SGD) (YeastGenome.org) with Tophat in Galaxy. With Cufflink, the
transcriptome was assembled using the reference annotation by comparing the reads to the
reference genome. Lastly, using Cuffdiff, the aligned sequence expression rates were compared
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between sample conditions, creating a list of differentially expressed genes (DEGs). When the
final differential gene data was obtained, genes with a q-value greater than 0.05 were not
included in the final list of genes analyzed. The remaining genes were grouped based on
correlating gene ontology (GO) terms obtained from GOrilla.
Quantitative Reverse Transcription PCR (RT-qPCR). Total RNA samples isolated
from three control and three experimental (AgNP or QD-treated) cell cultures were used to
produce cDNA with the Verso cDNA conversion kit (Thermo Fisher Scientific). The resulting
cDNA concentration was quantified with the Qubit 3.0 Fluorometer. A primer efficiency test was
performed to validate DNA primers and cDNA samples for reverse transcription quantitative
PCR (RT-qPCR) experiments. FAF1, SDA1, DAN1, TIR1, HXK1, SPS100, YDL012C, and
ALG9 primers were chosen for this test. FAF1, SDA1, DAN1 and TIR1 genes were chosen
because they were differentially expressed in AgNP- and yellow-emitting CdSe/ZnS-treated
samples (Chapters II and III) and TIR1, HXK1, SPS100, and YDL012C were chosen because
they were differentially expressed in green-emitting CdSe/ZnS-treated samples (Chapter IV),
while the expression of ALG9, a housekeeping gene, was not affected by the presence of any
nanomaterial. In this test, serially diluted cDNA (dilution factor of 5 or 2 depending on the
nanomaterial) samples with or without a fixed amount of primers were subjected to PCR
amplification using GoTaq qPCR kit (Promega, Madison, WI). The primer efficiency and Rsquared values were calculated with MxProR software (Agilent, Santa Clara, CA) and my Rsquared values for all primer sets were between 0.99 and 1.00, indicating good precision in the
preparation of the dilution assay. Primer efficiency values for all primers ranged from 1.69 to
2.14. After testing efficiency, 60 ng of cDNA from three control and three experimental samples
was used as a template for amplification of the cDNA for all genes by following the GoTaq
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qPCR Master Mix protocol (Promega) for AgNP and yellow-emitting CdSe/ZnS-treated samples
and using the PowerTrack SYBR Green Master Mix (ThermoFisher Scientific, Waltham, MA,
USA) for green-emitting CdSe/ZnS and InP/ZnS-treated samples. For each target gene to be
amplified, I prepared a non-treated control reaction mixture that contains all the same reagents
including primers, GoTaq Master Mix or PowerTRack SYBR Green Master Mix, and water
lacking any cDNA. After each well contained all reagents, primers, cDNA, and water, they were
thoroughly mixed by pipetting up and down. Once mixed, the plate was capped and centrifuged
for 1 min. Then, the 96-well plate was placed in the pre-heated MX3005p machine (Chapters II
and III) or the QuantStudio 6 Pro instrument (Thermo Fisher Scientific, Waltham, MA, USA,
USA) (Chapter IV) for PCR amplification. The pfaffl method was utilized to determine the
relative fold change in gene expression of a target gene in comparison to ALG9, a housekeeping
gene (Pfaffl 2001). The relative expression ratio of the target gene is calculated based on E (RTPCR efficiencies) and CP (crossing point) deviation versus the control and then the expression
was compared to that of ALG9.
Measurement of Reactive Oxygen Species. Reactive oxygen species (ROS) and
superoxide levels were quantified with flow cytometry, and the experiment was performed twice
in triplicate for each experiment (Chapters II-IV) testing 18 samples (per chapter). Each cell
containing sample was diluted to have an OD of 0.1 in 100 μL of SD-Glu media and incubated in
a shaking incubator for 6 h at 30◦C. At hour 6, 5 μg/mL of dihydrorhodamine 123 (DHR123) or
dihydroethidium (DHE) was added, and all samples were incubated for an additional 2 h before
being brought to 1 mL with 1X PBS buffer and quantified with flow cytometry (Attune NxT
acoustic focusing cytometer, Life Technologies). Samples 1–9 tested for the presence of
peroxynitrite ROS by utilizing the ROS indicator DHR123. Samples 10–18 tested for the
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presence of superoxide by similarly utilizing the superoxide indicator DHE. Samples 1–3 and
10–12 had a concentration of 0 μg/mL of AgNPs or yellow-emitting CdSe/ZnS QDs or greenemitting CdSe/ZnS QDs and InP/ZnS QDs, samples 4–6 and 13–15 had a concentration of 5
μg/mL AgNPs (Chapter II&III) or 10 μg/mL of green-emitting CdSe/ZnS and InP/ZnS QDs
(Chapter IV), and samples 7–9 and 16–18 had a concentration of 10 μg/mL AgNPs (Chapter II)
or 20 μg/mL yellow-emitting CdSe/ZnS QDs (Chapter III), and 100 μg/mL green-emitting
CdSe/ZnS or InP/ZnS QDs (Chapter IV). Once recorded with the cytometer, the data was gated
and customized to account for the % fluorescence of each target indicator (DHR123 and DHE) in
their respective sample.
Cell Wall Stability Assay (Chapter II). The cell wall integrity was tested with a cellwall-degrading enzyme, Zymolase 100T, in triplicate. Each cell sample was diluted to an OD of
1.0 in a total volume of 200 μL in a 96-well plate. Each well also contained 0 or 10 μg/mL of
Zymolase 100T and varying concentrations of AgNPs (0, 5 and 10 μg/mL). Once each sample
was plated, the 96-well plate was inserted into the ELx808 plate reader (BioTek) and the OD at
595 nm was recorded every 10 min for 6 h.
Nanoparticles’ Effects on Cells Lacking Cell Walls (Chapter III). The Zymolase
assay was performed by culturing yeast cells in 3 mL of SD-Glucose overnight in a shaking
incubator at 30 °C. The cell culture was then centrifuged at 2000× g for ten minutes, and the
resulting cell pellet was re-suspended with 2X TE buffer to an OD of 1.0. The suspended cells
were applied to a 96-well plate in a quadruplicate manner. To test the effects of green-emitting
CdSe/ZnS QDs, the following samples were prepared: non-treated controls (cells with TE
buffer), 10 µg/mL CdSe/ZnS-treated cells, and 20 µg/mL CdSe/ZnS-treated cells. To test the
effects of AgNPs, samples prepared in a 96-well plate consisted of non-treated controls and 2.5
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µg/mL and 5 µg/mL AgNP-treated cells. Cell walls were degraded by the introduction of
Zymolase at a concentration of 0.5 µg/mL and incubated in an ELx808 TM absorbance microplate
reader (Biotek, Winooski, VT) for four hours at 30 °C. During the incubation period, the optical
density (594 nm) was measured in 30 min intervals, and each sample was independently tested
without the use of Zymolase to serve as a control. The resulting changes in optical densities were
recorded and averaged for each sample before plotting into a line graph.
Confocal Microscopy Analysis (Chapter IV). Wild type cells expressing Vps10-GFP
were treated with CdSe/ZnS and InP/ZnS QDs, both QDs were treated at 10 μg/mL for six hours
at 30 °C in a shaking incubator. After incubation with the QDs, 500 μL of each sample was
transferred to a micro-centrifuge tube and centrifuged at 2000 rpm for 10 min. If a pellet was
visible, remove 300 μL of media was removed, without disturbing the pellet. Next, the pellets
were re-suspended by vortexing and transferred 2.8 μL of the concentrated sample onto a glass
slide, where a coverslip was gently applied to the droplet, and visualized the cells with a confocal
microscope. The green laser was used for confocal microscopy and the intensity was set to 200
to detect punctated Vps10-GFP with immunofluorescence images. I quantified the number of
Vps10-GFP puncta in NTC, CdSe/ZnS- (10 μg/mL), and InP/ZnS-treated (10 μg/mL) samples.
Statistical Analysis. In the cell viability assay (Figure 2), 100 cells from non-treated,
treated with 5 μg/mL and treated with 10 μg/mL samples were randomly selected, and levels of
viability were determined. This viability assay was repeated in triplicate, and the mean number
of viable cells in each of the three samples in each group was used to determine the final values
depicted in Figure 2. A two-tailed equal variance Student’s t-test was performed, and no
statistical difference was seen between the three sample groups suggesting AgNPs up to 10
μg/mL have no effect on cell viability measured by Fun1 fluorescent dye.
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RT-PCR was performed three times in triplicate for two target upregulated and
downregulated genes found to be statistically significant from a list of differentially expressed
genes created from the RNA-seq data. The resulting Ct values from RT-PCR were incorporated
in the Pfaffl method to determine each gene’s differential fold change. A similar Student’s t-test
was performed to determine P values.
ROS and superoxide levels were quantified with flow cytometry, and the experiment was
performed twice in triplicate with each experiment testing 18 samples. The mean value for each
group (Chapter II: 0, 5 and 10 μg/mL; Chapter III: 0, 5 μg/mL AgNP and 20 μg/mL yellowemitting CdSe/ZnS QDs; Chapter IV: 100 μg/mL green-emitting CdSe/ZnS and InP/ZnS QDs)
and corresponding standard deviation values were determined with a one-way ANOVA test.

Carbon Nanotubes
CNTs are an important and highly versatile class of ENMs that have a huge variety of
uses ranging from high performance batteries and touchscreens to drug delivery systems [8].
They can be described as nanoscopic cylinders, resembling chicken wire, that typically stand
shoulder to shoulder in a “nanotube forest” and is stronger and lighter than titanium. Their
superior tensile strength and toughness come from the extremely strong bonds between carbon
atoms that compose the nanotube structure. Their diverse capabilities have led to a fast-growing
market for CNTs, yet research on their mechanisms of toxicity are debated and not complete. As
a result, there has been an increase in CNT manufacturing, there is a strong possibility of
increased CNT exposure on the environment. Unfortunately, their nano-size make them
unpredictable and research on their biomechanics and toxicity in humans is limited. Until there is
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a better understanding of the effects of CNTs on human health, their efficacy in medicine and
safe use in manufactured products will remain unknown.
Previous studies have shown that exposure to CNTs can have toxic effects through the
generation of oxidative stress or by inducing inflammation. Multi-walled carbon nanotubes
(MWCNT) and single-walled carbon nanotubes (SWCNT) are two important classes of CNTs,
and their underlying mechanisms of toxicity have been investigated using RNA-seq. To have a
complete understanding of carbon nanotubes function in vivo, determining their structure is
essential. Nano-carbons are built from sp2 hybridized carbon atoms, a strong molecular
interaction which makes CNT more appealing in situations such as drug delivery [9]. The tubular
structure of SWCNT depicted each carbon joined by three neighboring carbons essentially
making a Sp2 hybridized structure [10]. The Sp2 structure of carbon nanotubes is greatly more
effective than the Sp3 hybridized structure that can be found among SWCNT. The Sp3 structure
can cause deformations by bending or twisting of the nanotube on the wall [10]. These structure
deformations can raise some concerns as well as the size of carbon nanotubes. SWCNTs can
have a diameter as small as .4 nm and MWCNT can range from 5-100 nm [9]. Smaller CNTs can
lead to an increased surface area and a greater potential opportunity for interaction and uptake by
living cells [11]. Most studies are in agreement that the smaller size of SWCNT show a greater
cytotoxic effect compared to MWCNT.
There is a study that was conducted in 2019 to investigate the changes in protein and
gene expression when Escherichia coli (E. coli) are exposed to SWCNTs: 10 and 100 μg/ml
pristine SWCNTs, and hydroxyl and carboxylic functionalized SWCNTs. Le et al., found that
there are more damages or death of E. coli cells in higher concentration of SWCNTs [12].
When E coli. were exposed at low concentration (10 μg/ml) of SWCNTs, E. coli produced phage
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shock pathway and altered protein regulations. At the high concentration (100 μg/ml) of
SWCNTs, several proteins were shut down [12]. Moreover, PspA gene expression (responded to
the membrane stressor) in cells exposed to 100 μg/ml SWCNTs was lower than that in the
control group because of increased cell damage or death [12]. Another study was conducted by
Yadav et al., in 2015 to investigate the toxic effect of MWCNTs on up flow anaerobic sludge
blanket (UASB) microbial activity. In their study, they found MWCNT has effects on microbial
viability: when the microbial cells were exposed to 1 and 100 mg/L of MWCNT, the reduction
of colony forming units (CFU) was 29% and 58%, respectively [13]. Additionally, they found
MWCNT-mediated damage to microbial cells [13]. Due to these findings, Le et al. and Yadav et
al. revealed SWCNTs and MWCNTs induced negative cytotoxic effects on E. coli.
In 2014, there was a study investigated the effects of SWCNTs on bacterial growth
and had similar results. In this study, Zheng et al., found that when the outside and inside
of P. denitrificans were exposed to 10 and 50 mg/L of carboxyl-modified SWCNTs in 8-20
hours, there was a kind of inhibiting effects on bacterial growth rates and densities. However,
non-modified SWCNTs was no significant effects on bacterial growth rates and densities during
the 24-hour exposure of 10 and 50 mg/L [14]. This result is due to carboxylmodified SWCNT that are transcriptional activators of genes encoding nucleotide reductases.
These reductases respond to DNA damage and reduce gene expression and energy production
associated with glucose metabolism. Furthermore, carboxyl-modified SWCNT leads to
significant downregulation of nitrate reductases, reducing their activity [14]. These results
highlight the influence physiochemical properties have on toxicity. Each CNT (modified and
non-modified SWCNTs), though extremely similar in structure and composition, had very
different effects on growth.
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Gene expression studies on bacteria, specifically Salmonella typhimurium, can help
clarify the mechanisms of CNT toxicity and if this treatment could be a possible anti-bacterial
agent. Salmonella typhimurium, a gram-negative food borne pathogen, was exposed to SWCNTs
in order to study the genes association with bacterial metabolism, structural integrity, and
antibacterial components of nanoparticles, using electron microscopy and molecular studies such
as qRT-PCR. Two silver coated carbon nanotubes (SWCNT-Aag and pSWCNT-Aag) are
predicted to have antibacterial activity mediated through generation of ROS from the bacterial
cells [15]. Interestingly, bacteria treated with plain SWCNT-Ag showed upregulation
of ychP gene (associated with invasion) and downregulation of ompF gene (outer membrane
protein). The bacteria treated with pSWCNT-Ag downregulated ompF, safC (outer membrane
protein), and ychP genes, but only upregulated cigR gene (inner membrane protein) [15]. The
expression of ompF, cigR, and ychP genes are all associated with membrane integrity and
consistently downregulated in both SWCNT-Ag and pSWCNT-Ag [15].
Interestingly, ychP and safC genes are exclusively downregulated in pSWCNT-Ag. In
summary, pSWCNT-Ag are non-toxic to human cells compared to SWCNTS-Ag. Experiments
show that pSWCNT-Ag proves to be a potential safe alternative antimicrobial agent to
treat food borne pathogens.
Woodmen et at emphasizes the effects of CNT on Saccharomyces cerevisiae [14]. This
model organism has fast cell division which is preferred for cell culture and treatment.
Also, being eukaryotic is adequate when comparing to more advanced organisms. RNAseq dependent transcriptional analysis constructed gene expression of CNT treated cells. Genes
related with membrane transport and stress response were differentially expressed in CNT
treated cells [14]. To conclude, CNT serves as environmental toxic factors to eukaryotic cells.
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In 2012, Guo et al., investigated multi-walled carbon nanotube-induced gene signature in
the mouse lungs and the association between these genes and human lung cancer risk and
prognosis. Mice in this experiment were divided into vehicle control group and multi-walled
carbon nanotubes (MWCNT) groups: Mice either received DM (vehicle control), 10, 20, 40 or
80 µg MWCNT [16]. Then, RNA was extracted and 24 genes were selected by using microarray
and linear modeling. These 24 genes have significant changes in at least two time points. Their
changes were more than 1.5 times at all doses. At day 56 after exposing to MWCNT, 330 genes
were differentially expressed, and 38 of them were related to cancer [16]. A closely related study
conducted with mouse lung revealed similar effects: a subset of mouse lung cancer biomarkers is
affected after exposing to MWCNT. In this study, mice were divided into different groups: mice
received either DM (vehicle control), 10, 20, 40 or 80 μg MWCNT [17]. Pancurari et al. found
that 7 of a total 63 lung cancer prognostic and major signaling biomarker genes had different
expression levels compared to the control group at 7 days after exposing to MWCNT, and 11
genes had different expression levels compared to the control group at 56 days after exposing to
MWCNT by using qRT-PCR. At 56 days after exposing to MWCNT, the gene expression level
of 3 overlapping genes was decreased compared to their expression level at 7 days [17]. Also,
among the 11-gene associated canonical pathways, the molecular mechanisms of cancer pathway
ranked the most significant at 56 days after exposure [17].
Moreover, there is another study conducted with mouse lung in 2014. Fujita et
al., investigated time dependent changes in gene expression associated with the pulmonary
toxicity of single-wall carbon nanotube (SWCNT). SWCNTs suspensions were administered one
time in each rat (0.2 mg or 0.4 mg). After dissection, researchers found that the appearance of
SWCNT aggregates decreased in a time-dependent manner [18]. In addition, at 90 days
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after SWCNT exposure, the persistence of macrophages laden with SWCNT aggregates
were observed in the alveolar walls and alveoli [18]. At 180 days, they observed macrophagecontaining granuloma around the sites of SWCNT aggregates. Additionally, many genes
involved in inflammatory response were significantly up-regulated on days 7, 90, and
180 and the number of up-regulated genes gradually decreased 180 days after instillation,
but increased again at 365 days [18].
Due to their excellent physical and chemical properties, carbon nanotubes have shown
potential application prospects in the fields of biology and medicine. From the long-term
development of nanotechnology, the safe application and potential toxicological evaluation of
carbon nanotubes are very important. With the deepening of research, it has been found that
carbon nanotubes have a wide range of applications in the field of biomedicine. However, due to
their small size and they can be deposited in the main organs of the human body, the possible
biological effects and safety in human cells have gradually become the focus of attention. A
previous study in 2014 investigated the correlation and concordance of MWCNT-induced gene
expression in vitro monoculture and co-culture of human small airway epithelial cells (SAEC)
and human microvascular endothelial cells (HMVEC) with gene expression in vivo mouse lung
exposed to MWCNT. Snyder-Talkington et al., compared MWCNT-induced mRNA gene
expression from human small airway epithelial cells (SAEC) and microvascular endothelial cells
(HMVEC) in monoculture and co-culture [19]. When human lung epithelial and microvascular
endothelial cells were co-cultured and treated with MWCNT, there were more concordant genes
(both up- or downregulated in vivo and in vitro) than those of monoculture, particularly diseaserelated concordant genes [16, 19]. Since the gene expression of co-culture model better
correlated to the in vivo gene expression, MWCNT could also be the potential biomarker for
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human lung diseases. A similar study was conducted in 2019 to explore the data of mRNA in the
mice and SAEC and HMVEC exposed to MWCNT. Snyder-Talkington et al. found that 4
concordant mRNAs (MYBPC2, PSD4, TMPRSS6, and S100A5) between mouse lung tissues
and SAEC exposing to MWCNT were upregulated and 40 concordant mRNAs were
downregulated [12]. Also, 4 concordant mRNAs (HIST1H3F, HIST1H2AL, MID1, and
NUDT8) between mouse lung tissues and HMVEC exposing to MWCNT were upregulated and
20 concordant mRNAs were downregulated [12]. Importantly, concordant mRNAs-- SLC7A1
and SLC22A5 were downregulated in all mice and human tissue, blood and cell analyses, which
could cause human primary hypertension, cardiovascular diseases, encephalopathy,
cardiomyopathy, cardiomegaly, metabolic derangement, hypoglycemia, and muscle
weakness [12]. This reveals that MWCNTs have similar effects in mouse and human models.
Treatment of CNT on human cells was conducted in a 2017 study. RT-PCR was used to
quantify the mRNA level of ddit3(chop) and xbp-1s, two gene biomarkers for ER stress. A recent
study found that ER stress caused possible dysfunction of endothelial cells via the ER stress
pathway when exposed to CNT [20]. Human umbilical vein endothelial cells (HUVECs) were
treated with 32 mg/mL of XFM22 (shorter MWCNT) and XFM19 (longer MWCNT) in a 6-well
plate [20]. Using specific primers for each gene, mRNA was quantified. Exposure of XFM22 to
the HUVECs decreased the expression of ddit3 in mRNA; whereas, when HUVECs were treated
with XFM19 the cells expressed significant increase in ddit3. The expression of xbp-1s gene
remained constant when treated with XFM22 but XFM19 downregulated the expression of xbp1s [20]. Ddit3 is a transcription factor that regulates inflammatory cytokines like IL-6. XFM19,
the longer MWCNT, increased ddit3 expression, meaning that XFM19 treated HUVEC cells
may be able to produce more IL-6. It is important to note that this study illustrates modest ER-
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stressed compared to studies conducted in the past. Overall, the treatment of XFM22 and XFM19
in HUVEC cells conveyed less ER stress than initially expected. The influence of MWCNT on
gene expression associated with ER stress in in HUVECs was also investigated in 2018. Chang
et al. found the expression of genes associated with ER was induced by high concentrations of
MWCNTs in HUVECs cultured in the upper chambers, such as HSPA5, DDIT3 and XBP1s [13]. In summation, they provided evidence of CNTs negatively affecting HUVECs via ER
damage.
In 2010, Patlolla et al., tested potential effects of MWCNT on normal human dermal
fibroblast (NHDF) cells based on three doses: 40, 200, and 400 μg/mL [21]. After exposure to
different concentrations of MWCNT, cell viability was significantly reduced, especially at the
highest dose. The cytotoxicity appeared to be dose dependent and increased as the dose
concentration increased [21]. Additionally, they tested genotoxicity and apoptosis for NHDF
cells and found a direct correlation between the concentration of MWCNT and the levels of tail
DNA, which is a parameter in evaluating cell DNA damage. Notably, the percentage of
apoptosis increased with the increasing doses of MWCNT [21]. In another study, Siegrist et al.,
also tested the genotoxicity effects of MWCNTs on the cultured primary and immortalized
human airway epithelial cells, and their results showed there was an increase in spindle
disruption, abnormal mitotic spindles, and aneuploid chromosome number with the increased
doses of MWCNTs. Thus, they revealed MWCNTs to cause dose-dependent genetic damage
[22]. Furthermore, in 2019, Snyder et al., employed qPCR to measure the potential effects of
MWCNTs on mitochondrial gene expression in human bronchial epithelial cells (BECs) after
exposing to up to 3 μg/ml of MWCNTs. As the result, the mitochondrial gene expression in
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some BECs was significantly upregulated [9, 23]. All data demonstrated the levels of DNA and
mitochondrial damages in human cell lines were increased by MWCNT.
In conclusion, the potential effects of CNTs on gene expressions was studied to promote
the application of nanotechnology and the development of nanoparticles. Although they are a
very popular nanoparticle for biomedical applications, several studies have also demonstrated
that CNTs can be harmful by affecting gene expression and protein pathways. Those studies
demonstrated the exposure of bacteria, fungi, animal and human tissues to CNTs led to upregulation of gene expression for oxidative stress, inflammation, and cancers. These articles
provided empirical evidence and support for an accurate assessment of the potential risks in
bacteria, animal, and human models that will help us to better understand their long-term effects
on our health and the environment. The effect of CNTs on gene expression may serve as a
potential biomarker for human medical and occupational monitoring in future studies. Due to the
lack of research on gene expression, the production and use of CNTs in biomedical technologies
such as disease diagnosis and drug delivery are still at risk. Hopefully, they can be used
responsibly after more investigations have been conducted on their unique properties and affects
on gene expressions.

Quantum Dots
Quantum dots are a new class of ENMs, with a diameter of 2-10 nm [11, 12, 14], that
possess unique physical and chemical properties that include high stability, narrow emission
ranges, and high quantum yield [13]. Therefore, QDs are broadly used in biosensors, molecular
imaging, multicolored labeling, drug carrier cosmetics, therapeutic targeting, photodynamic
therapy, and real-time tracking [13, 14]. Most QDs are considered non-toxic and as a result are
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of enormous interest in chemical, catalytic, electronic, optical, mechanical, magnetic, and
medical fields and are becoming more common in many diverse commercial and industrial
sectors, including but not limited to, textiles, medical products, cosmetics, paints, and plastics
[2]. Similar to CNTs, QDs are a potential smart drug delivery vehicle in new and innovative
cancer treatments [15]. Their photo-stability, tunable emission, and broad excitation range make
them a more effective fluorescent tag than organic dyes in biological applications (protein labels,
real-time trackers, and FRET sensors) [16, 17]. Previously, there have been conflicting results
regarding QD cytotoxicity due to their diverse physiochemical properties (size, charge,
composition, concentration, outer coating bioactivity, and stability) believed to be determining
factors of toxicity [12, 18, 19]. Thus, the high possible combinations of properties result in a
wide possibility of cytotoxic effects. Cytotoxicity has been investigated extensively; the scope of
this section is to provide the most relevant and current findings on the transcriptomic effects of
QDs on the cellular and organismal level.
Given the exceedingly broad potential applications of QDs, it is vital to resolve their
toxic effects in prokaryotic and eukaryotic organisms. To date, very few global transcriptomic
analyses of the effects of QD exposure on bacterial toxicity have been reported on. A study on
the response of E. coli to CdTe-GSH QDs revealed that the same QD displayed differential
toxicity based on size. Red QDs were found to be more toxic than green QDs when treated to E.
coli at MICs of 125 and 2000 μg/mL, respectively. To determine the bacteria's global response to
QDs of both sizes, microarray analysis was used to measure changes in gene expression. 95
genes were altered in response to red QDs while only 42 genes were changed in response to
green QDs. Moreover, there were 7 genes differentially regulated by both QDs that gene
ontology (GO) analysis reported to be implicated in processes related to transport, biosynthesis,
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and metabolism. Furthermore, red QDs upregulated genes related to glycolysis and the TCA
cycle slightly and transport by nearly 4-fold compared to green QD exposure [14]. Additionally,
a transcriptomic response of Pseudomonas stutzeri exposed to cationic polythylenimine (PEI)
coated CdSe/CdZnS QDs was observed. Changes in 7 genes, mostly implicated in denitrification
(narG, napB, nirH, and norB) and the upregulation of superoxide dismutase (sodB), suggests the
production of ROS as a response to QD exposure [20]. Correspondingly, Yang et al. found P.
aeruginosa PAO1 exposed to CdSe QDs altered the expression of genes implicated in response
to heavy metals and oxidative stress [21].
With RNA-seq, Horstmann et al. investigated the effects of CdSe/ZnS QDs on the yeast
Saccharomyces cerevisiae and found exposure to the QDs had resulted in thousands of DEGs
most notably involved in rRNA transcription, ribosomal subunit assembly, ribosomal subunit
transport, tRNA maturation, and translation machinery assembly [22]. Hosiner et al. (2014) used
microarray to investigate the effects of several metal ions (CdCl2) on Saccharomyces cerevisiae
and found antioxidant genes and redox homeostasis genes to be upregulated, such as GRX2 and
TRR1, TRR2, and TRX3, respectively [23]. Interestingly, in 2016 researchers exploited a mutant
S. cerevisiae strain to identify the genetic basis of CdS QD resistance. They found that in
response to CdS QD exposure, several metabolic processes were altered, including abiotic stress
response, mitochondrial organization, transport, and DNA repair [24]. The same research team
later conducted a transcriptomic analysis and found mitochondrion organization as the primary
functional category affected genes fell under. Additionally, they observed diminished oxygen
consumption, cytochrome content, and mitochondrial membrane potential [25].
A recent study on soybean tissue investigated the effects of CdS QDs on transport
proteins and biological pathways. Majumdar et al. (2019) identified 1690 genes that were
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common between each CdS-QD treatment and GO term analysis suggests the affected proteins in
CdS-exposed soybean roots are localized in the cell wall, extracellular region, membrane-bound
organelles, and function as integral components of the membrane [26]. CdS-QD-treated soybean
root tissue has been found to significantly alter protein levels involved in transmembrane
transport of metal ions or protons, chitin binding, carbohydrate metabolism, and responding to
oxidative stress [26]. Interestingly, short-term CdS-QD exposure (14 days) on soybean roots
were found to upregulate cytosolic proteins involved in metabolic pathways including glycolysis,
the TCA cycle, fatty acid β-oxidation, amino acid biosynthesis, and secondary metabolite
biosynthesis. Upregulated cytosolic proteins responsible for converting proteins into useable
substrates involved in the TCA cycle were unique to CdS-QD exposure. Additionally,
downregulated proteins involved in glycogen metabolism (such as uridine-triphosphate- (UTP)
glucose-1-phosphate uridylyltransferase involved in uridine diphosphate-glucose (UDP-glucose)
regeneration from glucose-1-phosphate) were identified suggesting that CdS-QD exposure alters
soybean metabolic pathways to favor glycolysis [26]. Similarly, in 2013, Simon et al. utilized
RNA-seq to investigate the effects of CdTe/CdS QDs on green algae and identified, through GO
analysis, DEGs involved in oxidative stress, redox potential, protein folding, and chaperone
activity processes [27].
A 2010 study investigated the geno-toxic effects of green CdSe (455 nm), blue Cd1xZnxS/ZnS (550 nm), and red CdSe/ZnS (625 nm) QDs on human embryonic kidney fibroblast
cells (HEK293) by whole-genome microarray. HEK293 cells were treated with 200 nM, 60 nM,
and 10 nM of red, blue, and green QDs, respectively. Interestingly, more genes were upregulated
in green and blue QD treated cells and red QD treated samples downregulated more genes. GOterm analysis of DEGs showed that response to wounding, cell stress, apoptosis, and defense
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response functions were enriched in all three of the QDs tested. The expression of
metallothionein superfamily genes were induced when treated with red and green QDs, however,
these genes were not affected in blue QD treated samples. Metallothioneins (MTX2a, MTX1h,
MTX1g, MTX1f) are metal binding proteins that play a role in detoxification and protect against
ROS and are also upregulated when exposed to Cd2+ ions [28].
Zhang et al., 2006 investigated PEG-silane-CdSe/ZnS QDs on human skin fibroblasts
(HSF-42) with a genome-wide expression array analysis at concentrations of 8 and 80 nM.
Approximately 50 genes had significantly altered expression levels greater than 2-fold and were
found to be involved in carbohydrate binding, intracellular vesicle formation, and cellular
response to stress. Interestingly, PEG-silane-QDs were found to downregulate genes involved in
modulating the M-phase progression of mitosis, spindle formation, and cytokinesis. However,
PEG-silane-QDs do not induce immune and inflammatory responses or heavy metal related
toxicity, unlike exposure to CNTs. This study provided evidence that if CdSe/ZnS QDs are
appropriately coated they will have very little impact on HSF-42 cells and PEG-coated QDs do
not pose a major threat and reduce the toxicity of CdSe/ZnS QDs [29].
Unlike previous gene expression studies that mainly focus on fibroblast cell lines, a new
2020 study investigated the effects of Cd QDs on the growth of human cervical cancer cells
(HeLa). Hens et al., 2020 implemented the RNA-seq method to analyze transcriptomic changes
in HeLa cells when exposed to QDs. They identified many significantly up- and down-regulated
genes and conveniently grouped them based on their functions using GO-terms. When exposed
to QDs, they observed upregulated cellular functions in HeLa cells such as anti-apoptotic, antiproliferative, and anti-tumorigenic functions. Additionally, they identified downregulated
functions including pro-proliferation, mitochondrial respiratory chain, detoxification, and
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receptor-mediated endocytosis. Based on new insights from their transcriptomic analysis, they
provide evidence that CdSe/ZnS QDs could be effective as an alternative anticancer drug [6]. A
similar study was conducted by Davenport et al., 2021 used InP/ZnS QDs on HeLa cells. Their
RNA-seq and gene expression analysis revealed many genes involved in developmental
processes including differentiation, tissue and nervous system development, and morphogenesis
to be upregulated. They also found major processes such as metabolic and biosynthetic processes
to be significantly downregulated. Both up- and down- regulated processes suggested expression
of pro-apoptotic gene processes and control over cell motility [7]. They, like Hens et al., 2020
suggested the QD treatment be considered for anticancer drug development [7]. Additionally,
carboxylated CdSe/ZnS QDs upregulated genes implicated in DNA repair, responding to stress,
ATP functions, and RNA activities and downregulates genes involved in cellular division in
alveolar epithelial cells [30].
In summation, Cd based QDs, despite their different spectral characteristics and
composition, display toxic effects. Dua et al. and coworkers found with microarray analysis, QD
exposure induces the expression of genes involved in oxidative stress, apoptosis, and
inflammation that result in decreased cellular viability. Furthermore, they stated QD-mediated
toxicity is highly dependent on the core material (CdSe) and the coating (ZnS) partially reduces
the toxic effects [28]. Their results suggest that the use of unmodified QDs in biomedical
applications should be used carefully and with much consideration. Contrarily, Zhang et al.
showed by adding a polymer coat, such as a PEG-silica-coat, it allows for their safe use in vivo.
They provided evidence with a comprehensive analysis of genome-wide expression alterations
that PEG-silica-coated CdSe/ZnS QDs have minimal impacts on cellular health. These results
contradict many popular beliefs that CdSe-based QDs are toxic due to Cd2+ leakage. These
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potentially safer polymer coated QDs could be a large step toward their safe and widespread use
in biomedical studies and applications [29]. These initial findings provide a solid foundation on
QD toxicity necessary in identifying patterns in altered gene expression levels that will
ultimately help build a network of global transcriptomic data on lower and higher organisms
exposed to QDs. Future studies should focus on QDs long-term fate in living organisms,
including their breakdown, to help better fully understand their toxicity. Understanding their
effects in biological systems is crucial if we want to responsibly continue to use or incorporate
them in industrial or commercial settings in the future.

Ag Nanoparticles
Silver has been studied and used for thousands of years in the medical and engineering
fields because of its antimicrobial properties against bacteria, viruses, and fungi [31, 32]. In
recent decades, the use of silver has been studied on a micro level in the form of nanoparticles.
Silver nanoparticles (AgNP) range from 1-100 nm in size and have gained popularity for their
optical, thermal, and electrical properties [33, 34]. With increasing levels of antibiotic resistance,
AgNP have been hypothesized as a solution for improving current antibiotic treatment options
for diseases like tuberculosis [35]. More specifically, AgNP have been used to innovate water
disinfection, medical diagnostics, pharmaceutical development, anti-cancer therapies, and
agriculture/live stock treatment [35-37]. While silver is found in many daily activities, AgNP
production and application have potentially toxic effects. AgNP exposure in humans has been
linked to disrupting function of mitochondria, sperm cells, and cytokine expression [38]. Studies
on AgNP toxicity are widespread in focus; this thesis is specifically interested in the effect of
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AgNP on gene function and transcriptome alterations across species. The scope of this section
will summarize current findings on AgNPs effect on the transcriptome of different organisms.
As mentioned, AgNPs are known for having antimicrobial/bacterial activity and have
been widely studied against various bacterial strains. It has been hypothesized that AgNP could
decrease antibacterial activity to be an alternative to antibiotics in treating bacterial infections.
To test this hypothesis, Ashmore et. al. studied AgNPs against E. coli using qRT-PCR.
Supporting the proposed hypothesis, their findings show AgNPs to significantly downregulate
genes associated with TCA cycle (aceF, gadB) and amino acid metabolism (argC, metL, gadB),
pointing to effective antibacterial properties of AgNPs. The downregulated genes positively
correlate with the proposed hypothesis, however there was upregulation in genes relevant to
bacterial virulence (fliC, msbB) and DNA repair mechanisms (mfD) as well [38]. Similarly,
antimicrobial effects of AgNP have been studied against Staphylococcus aureus and
Staphylococcus epidermidis that produce biofilms and cause biomaterial-related infections in
surgically inserted devices [39]. Through qRT-PCR methods, genes implicated in biofilm
formation (icaA and icaR in S. epidermidis, fnbA and fnbB in S. aureus) were significantly
downregulated with the presence of AgNP; these results conclude AgNP to inhibit transcription
of biofilm related genes and to be inhibitory towards S. aureus and S. epidermidis bacteria [39].
An important regulator of S. aureus growth is found in small regulatory RNAs (sRNA) that
require Hfq protein to mediate sRNA and their target mRNA [40]. Targeting activity of Hfq with
AgNPs for antibacterial treatment was studied by Tian et. al. in which they specifically
investigated sRNA-TEG49 expression (a key mediator of Hfq) [41]. Once again qRT-PCR was
used along with high-throughput RNA sequencing and northern blot analysis. AgNP exposure to
S. aureus resulted in loss-of-function of Hfq and subsequent inhibition of sRNA-TEG49. These
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results suggest regulation of Hfq function with AgNP to be important to the NPs antibacterial
mechanisms [41]. Collectively, applications of AgNPs against different bacteria support claims
that they are effective in altering gene function to control bacterial growth.
Many different fungal species are involved in pathogenesis affecting mammalian life and
need effective prevention and treatment methods. Along with their antibacterial properties,
AgNPs have been investigated for potential antifungal properties as well. Some fungi have been
investigated for their production of aflatoxins (AF), such as Aspergillus flavus and Aspergillus
parasiticus. Aflatoxin B1 (AFB1) has been identified in these fungi and classified as a group 1
carcinogen to mammals; the use of AgNPs as treatment to inhibit AFB1 production is proposed
by Deabes et al. [42]. It was previously reported that there are three main genes responsible for
aflatoxin biosynthesis: aksA, ver-1, and omt-A [43]. Within their study, Deabes et. al. measured
expression levels of these three genes, along with the AFB1 gene itself, in A. flavus ATCC28542
using qRT-PCR. Their findings showed inhibited AFB1 and omt-A expression, leading them to
conclude AgNPs to be effective in preventing AF production by A. flavus [42].
In some fungi, synthesis of structural molecules aid in their pathogenicity- as seen in
Bipolaris sorokiniana and melanin production [44]. Specifically related to melanin production,
expression of genes viz, PKS1, and SCD1 were observed using qRT-PCR. Downregulation of
genes PKS1 and SCD1 were observed in B. sorokiniana exposed to AgNPs, concluding the
treatment to reduce melanin synthesis [44]. These results suggest AgNP to be viable in
antifungal treatment, but the authors note further investigation is needed to understand the
correlation between pathogenicity and melanin production in B. sorokiniana.
In addition to pathogenic fungi, other related species are commonly used as model
organisms for studying biological processes. Szhizosaccharomyces pombe (fission yeast) is
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commonly used to study cell morphogenesis and division; after constructing a genome-wide
deletion library of fission yeast, Lee et. al. used the organism to identify target genes for
tolerance against AgNP-induced cytotoxicity [45]. Target screening and q-PCR were used to
identify 7 nonessential genes related to sulfur metabolism (gcs1, gcs2, hmt2, and rdl2) and
MAPK kinase signaling (mcs4, wis4 and SPCC1827.07c), all of which were previously linked to
metal resistance and stress response. Three essential genes (met9, sfh1, and peg1) related to
carbon metabolism were linked to AgNP-induced cytotoxicity for the first time [45]. The
findings of this study are important to understanding genetic defenses against AgNP cytotoxicity
within fission yeast.
Other fungal species, such as Folsomia candida and Saccharomyces cerevisiae, are often
studied because they culture easily and grow quickly. Both F. candida and S. cerevisiae were
studied by Sillapawattana et. al. to understand molecular toxicity of AgNPs and propose their
relevance as eukaryotic model organisms in ecotoxicological testing. Target genes GST and MT
were measured using qRT-PCR; F. candida observed upregulation of target genes when exposed
to AgNPs, demonstrating the organism’s ability to respond to a changing environment and use
employed gene expression to examine chemical effects in toxicogenomic studies [46]. Observing
the yeast genome showed code for only one cytosolic and one mitochondrial enzyme. This
exemplifies the handling of yeast for chemogenetic screening to understand AgNP toxicity in
yeast [46].
AgNP toxicity in S. cerevisiae was also investigated by Horstmann et. al. After observing
decreased viability following AgNP treatment, RNAseq was used to identify genetic alterations
to the yeast. Specifically, upregulated gene processes are suggested to disrupt healthy ribosome
function and successive rRNA/tRNA synthesis [47]. The study also analyzes downregulated
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processes that point to a defect in cell wall organization [47]. Conclusively, AgNP toxicity in
yeast appeared to be heavily influenced by gene expression alterations.
Expanding from bacterial and fungal treatments, AgNPs have been proposed for medical
therapies and technologies as well. To understand the positive and negative results of using
AgNPs in humans, scientists have turned to various human cell lines and mice models for
answers. Within these efforts, it is important to focus on gene expression changes to determine
how the NPs interact with the cell. Using RNA-seq, Gurenathan et. al. observed changes to gene
expression of in vitro NIH3T3 mouse embryonic fibroblasts. Alteration of processes involving
epigenetics, such as nucleosome assembly and DNA methylation were found when treated with
AgNPs. The study also found increased levels of apoptosis, which the authors suggest is
influenced by a repression of genes related to cell survival [48]. In a similar model, mice neural
cells were observed with AgNPs to relate gene expression changes to the development of
neurological disorders like Alzheimer’s disease. RT-PCR and western blot revealed increased
gene expression related to the Amyloid beta peptide responsible for causing Alzheimer’s (Genes
GSS, CYCL13, and MARCO) [49]. The conclusions from this RT-PCR analysis suggests AgNP
exposure accelerates the formation of plaque associated with Alzheimer’s disease and
emphasizes a need to monitor our daily interaction with Ag.
The toxicity of AgNPs is prevalent, however its properties have potential to be productive
as well. The use of AgNPs as an anti-cancer treatment shows potential for applying toxic
properties to cancer cells to destroy them. This was observed in combination with another cancer
treatment, campotothecin (CPT) in cervical cancer cells (HeLa) by Yuan et. al. The combined
treatments increased expression of proapoptotic genes like p53, p21, Cyt C, Bid, Bax, and Bak;
modification of signaling molecule expression related to cell survival, viability, and cytotoxicity
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were also observed [50]. NGS has also been used to show negative effect of AgNP treatment on
human lung cells; evidence of DNA damage raises concern for human exposure in vitro [51]. It
is suggested that the combination of these therapies, at low enough doses, could be successful at
inducing apoptosis in cancer cells without causing unwanted cytotoxic effects [50].
The study of AgNPs in human tissue is crucial to discovering the strengths/limitations of
their application to human cancer. Opposing their anti-cancer potential, recent evidence shows
AgNPs to alter genetic expression to increase susceptibility to carcinogens [52]. Our
understanding of the long-term in vitro effects on carcinogenicity can be improved by future
studies of these nanoparticles [51]. The future use of genomic studies will be valuable for
advancing the applications of AgNPs in the oncology field.
In conclusion, the use of AgNPs has greatly impacted antibacterial, anticancer, and
antifungal treatment methods. This review only touches the surface of data that has been
reported, but shows evidence concluding AgNPs to be effective in the alteration of gene
expression among species. While its properties are promising, careful consideration is still
needed in reference to their toxicity within mammalian cells. Going forward, more research is
needed to understand what levels of AgNPs are safe for human consumption and ways to harness
their toxicity so that they can continue to be an effective treatment against pathogenesis.

Future Trends
High-throughput sequencing technology has allowed researchers to observe the slightest
changes in transcript levels and has given us much insight on the effects of ENMs on many
different cell types and organisms. However, these modern genomic approaches like RNA-seq
and DNA Microarray are not a perfect science. Simply because the number of mRNA is
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increased or decreased in the presence of an ENM does not necessarily mean there are more
proteins being translated. Future trends in this field need to include proteomic studies to verify
changes in transcript levels found with gene expression studies. Through coupling gene
expression studies with proteomic studies, we can gain a clearer understanding of the molecular
changes, especially changes in protein levels, ENMs have on the cellular or organismal level.
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CHAPTER 2: TRANSCRIPTOME PROFILE WITH 20 NM SILVER NANOPARTICLES
IN YEAST

Introduction
Engineered nanomaterials (ENMs) are valuable and unique due to their small size, large
surface-area-to-volume ratio, aggregation, chemical composition, solubility and shape [53]. They
are currently used in over 1000 commercially avail- able products, ranging from sunscreens to
water-resistant sur- faces [54]. ENMs have been predicted to play a part in future-targeted
disease treatment, nanorobotics and next-generation electronics. Although the application of
ENMs is increasing almost daily, our understanding of their toxicity is lagging behind the
technology, thus encumbering safe and rapid deployment of these materials. In order to
responsibly use these technologies, understanding how ENMs interact with the environment is a
necessity. Their size allows them to interact at a molecular level, making them potentially useful
in many applications; however, it also makes them potentially dangerous.
Nearly every class of ENMs has been found to have some negative biological effects; the
question however is whether or not these effects pose a significant health or environmental risk
[55, 56]. In order to determine whether a particular ENM is toxic or not, one must consider the
specific properties of the materials being investigated, such as size, shape, etc. Studies have
shown that even between batches of nanomaterials, toxicity may vary. Many studies in academia
and industry have attempted to develop methods of understanding the toxicity of ENMs. Gold
nanoparticles (GNPs) have gained considerable attention for potential application in cancer
treatment such as photothermal therapy [57], and it was found that GNPs of different sizes are
not inherently toxic to human cells including keratinocytes and leukemia [58, 59]. However, 2
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nm GNPs functionalized with both cationic and an- ionic surface groups were toxic [60].
Another metal nanomaterial that has been widely used in a range of biomedical applications,
including diagnosis, treatment, drug delivery and medical device coating, is silver nanoparticles
(AgNPs) [61]. While it is well known that AgNPs exhibit antibacterial [62], antifungal, antiviral
[63] and anti-inflammatory properties [64], there exists a report demonstrating that AgNPs at 100
μg/mL with different sizes in HaCat cells are not toxic [65]. Although the mechanism underlying
their toxicity in different cells and organisms is not yet fully understood, the general consensus is
that AgNPs cause cell membrane disruption [66-68], as well as oxidative stress [69, 70].
An emerging ideal tool to assess how an organism responds to a spectrum of ENMs is
RNA-seq analysis that involves quantification of the expression of its genome. This highthroughput genomic/transcriptomic technology has been implemented for investigating the
effects of AgNPs in aquatic organisms, soil invertebrates, green algae and bacteria [27, 63, 71,
72] and revealed that AgNPs cause differential expression of transcripts encoding components of
the cell wall. Consistently, recent cell biological analyses with Candida albicans, a pathogenic
fungus, have shown that AgNPs disrupt the membrane [62], induce apoptosis [73] and cause
ultrastructural changes [74]. However, little is known about transcriptomic profiles of fungal
cells treated with AgNPs. Therefore, the present study has used the budding yeast,
Saccharomyces cerevisiae, to assess effects of AgNPs on the transcriptional activities of
individual genes, offering a comprehensive picture of cellular function in the presence of AgNPs.
The rationale for the use of S. cerevisiae was that it is one of the simplest eukaryotic organisms,
but carries genes and their corresponding proteins that function in a spectrum of biological
processes taking place in our cells. Another purpose of this study is to provide a standard
operating procedure for assessing the effects of nanomaterials on fungal organisms be- fore they
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are put into the environment. I reveal that a sub-lethal amount (5 μg/mL) of 20 nm spherical
AgNPs in yeast culture leads to a significant change in transcriptome pro le when compared with
non-treated cell culture, supporting the notion that AgNPs are environmental stress factors.

Results
AgNPs Negatively Affect Yeast Growth. To investigate the effects of spherical AgNPs
(∼20 nm in diameter) on the yeast growth, unicellular budding yeast cells were incubated for 24
h at 30◦C at varying concentrations of AgNPs (0–10 μg/mL) (Figure 1A). I observed that the
mean growth rate for three non-treated controls was similar to those of AgNP-treated compared
groups when the tested AgNP concentrations were below 5 μg/mL (Fig. 1A). However, a
treatment with more than or equal to 5 μg/mL of AgNPs led to a significant growth rate
reduction compared with non-treated controls. The mean maximum ODs at 600 nm reached by
cells exposed to 10 and 5 μg/mL of AgNPs were 0.57 ± 0.2 and 1.61 ± 0.03, respectively,
compared to the average maximum OD at 600 nm (1.73 ± 0.01) reached by non-treated control
experiments (Fig. 1B). The average amount of time during the growth cycle spent in lag phase
for each concentration below 5 μg/mL was very similar to the time spent in lag phase for the
controls (10.6 ± 0.3 h) (Fig. 1C). However, the average times spent in lag phase by cells grown
in 5 μg/mL (13.2 ± 0.80 h) and 10 μg/mL (19.9 ± 0.54 h) of AgNPs were significantly longer
than that of the control (10.6 ± 0.3 h) (Fig. 1C). The mean doubling times of control cells (1.28 ±
0.13 h) was the shortest among all experiments, and the corresponding doubling time for each
AgNP-treated culture increased in a dose-dependent manner. In particular, the doubling times of
the cells exposed to AgNP concentrations of 5 and 10 μg/mL were 1.8 ± 0.24 and 2.7 ± 0.15 h,
respectively (Fig. 1D). Taken together, these results suggest that exposure to AgNPs at
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concentrations higher than 5 μg/mL inhibits the efficient growth of exposed yeast cells. Ivask et
al (2014) previously demonstrated that AgNO3 is more toxic than AgNPs when they are similar
in size [75]. Therefore, I tested the effect of AgNO3 on yeast cell growth and found that the cell
culture with 0.05 μg/mL of AgNO3 showed a slower rate of yeast growth than the non-treated
control culture. The culture with 0.1 μg/mL did not support yeast growth, suggesting that 0.1
μg/mLAgNO3 is minimum inhibitory concentration. My experiment with AgNO3 indicates that
free silver ions affect more negatively on yeast proliferation.
Measurement of FUN-1 Dye Transport to the Vacuole. FUN-1 dye staining assay is
often used as a live/dead assay for yeast. The dye enters the cytoplasm where it emits green
fluorescence. As transported to the vacuolar lumen, it selfassembles into fluorescent red
cylindrical intravascuolar structures (CIVS) [8]. In an attempt to understand what may cause
growth defects in the presence of AgNPs, yeast cells were incubated with FUN-1 dye (20 μM,
final concentration) with or without AgNPs. Yeast cells emitting green fluorescence in the
cytoplasm with visible CIVS in the vacuole are considered active cells due to the process in
which they transport the dye to the vacuole (Figure 2A, left), whereas cells emitting green
fluorescence in the cytoplasm with no visible CIVS are considered metabolically inactive or
presumed to be dead (Figure 2A, right). From all yeast cells exposed to 0, 5 and 10 μg/mL of
AgNPs for 5 h, I found no significant difference in the percentage of cells showing the metabolic
activity of FUN1 dye transfer to form CIVS between the exposure concentrations and the control
(Figure 2B and C). Regardless of the presence or absence of AgNPs, at any concentration, over
90% of the cells were found to have no defect in transporting FUN-1 dye to the vacuole,
indicating no effect of AgNP treatment on the trafficking of FUN-1 dye to the vacuole.
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cDNA Sequencing Reveals Up- and Downregulated Genes with AgNPs. In lieu of
harnessing 1000 different metabolic assays to identify changes occurring in the cell treated with
AgNPs, I wanted to determine differential gene expression that may have occurred in response to
5 μg/mL of AgNP exposure by examining the transcriptional profiles of S. cerevisiae. I utilized
RNA-Seq (sequencing of cDNA) to determine the expression profiles of both the control and
AgNP-treated cells. Cells were grown and tested in triplicates, and I then performed a total RNA
extraction, isolated mRNA and converted it into cDNA for sequencing (Figure 3A). After
trimming and processing through Galaxy, a total of 42,808,285 accepted reads were obtained
from three control and three AgNP-treated samples. Of these clean reads, an average of 92.0 and
93.5% of the total reads mapped to the reference genome (S288C) in the absence and presence of
AgNPs, respectively, indicating that the sequenced reads accurately reflect the transcriptional
expression of S. cerevisiae. I identified 7126 genes (including non-coding cDNA), of which
expression levels of 1845 genes in AgNP-treated samples were found to be statistically different
from those of non-treated control samples (q-values < 0.05) (Table 1). Of these, 1077 genes were
upregulated and 768 genes were downregulated. My GO-term analysis with SGD revealed that
60% of all statistically upregulated genes (651 out of 1077) are implicated in nitrogen compound
metabolism, and that genes functioning in gene expression comprise up to 49.6% (Figure 3A).
Many upregulated genes are found to be implicated in ribosome biogenesis (26.4%), RNA
processing (24.8%), translation (20%) or translational initiation (2.5%). Among 285 upregulated
genes in the ribosome biogenesis category (Figure 3A), 268 genes are found to be functioning for
rRNA processing. Genes involved in single organism metabolic process comprise up to 25.3% of
all statistically downregulated genes (195 out of 768) (Figure 3B).
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To understand how cellular mRNA level changes upon the treatment of AgNPs, I
selected 144 most upregulated and 144 most downregulated genes, a total of 288 genes.
Consistent with the data shown in Figure 3A, the vast majority of highly upregulated genes are
implicated in the following, but not limited to, cellular processes: rRNA processing, ribosome
biogenesis, nuclear export, rRNA transcription, response to chemicals, protein targeting,
chromatin organization, DNA replication, cellular response to DNA damage stimulus, DNA
repair and response to oxidative stress (Figure 4A and Table 2). In the ‘rRNA processing’
category, DBP2 and FAF1 genes are 7.9-fold and 7.2- fold upregulated. However, the most
significantly upregulated gene is CTR1, a copper transporter that mediates nearly all copper
uptake under low copper conditions.
My GO-term analysis with 144 most downregulated genes displayed that 38 out of 144
genes are unknown in their function (Figure 4B and Table 3). More than a dozen genes (15 out
of 144) are identified to be involved in lipid metabolic processes, including genes implicated in
ergosterol synthesis (ERG11, ERG25, ERG28, ERG3, ERG5, and ERG6). Among 12
downregulated transmembrane transporters, 2 genes, AAC3 and MPC3, are implicated in
transporting ADP/ATP at the inner membrane of mitochondria and in transporting pyruvate to
mitochondria, respectively. More genes whose functions are implicated in mitochondriamediated cellular respiration are highly downregulated. These include AAC3, ACO1 (required
for TCA cycle), CIT3 (citrate synthase) and ISF1 (affecting mitochondrial function). I identified
11 genes that play a role in responding to chemicals. In particular, 4 genes (GRX6, TSA2, VHR1
and ZTA1) out of these 11 downregulated genes are involved in an oxidative stress response,
while 2 genes (CIN5 and NRG2) play a role in regulating the osmotic stress response. Among 10
genes involved in cell wall organization or biogenesis, 4 genes (GIP1, GSC2, OSW2 and
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SPO73) function for spore cell wall formation, whereas the rest (TIP1, TIR1, TIR2, TIR3, TIR4
and DAN1) are cell wall mannoproteins. In particular, DAN1 that codes for a cell wall
mannoprotein displayed 174-fold downregulation with AgNPs.
Validation of RNA-Seq Data by RT-qPCR. To validate the gene fold-change data
obtained through a RNAseq method, a real-time RT-qPCR test was used. Two upregulated genes
(FAF1 and SDA1) functioning in rRNA processing/ribosome biogenesis and two downregulated
genes (DAN1 and TIR1) coding for cell wall mannoproteins were chosen as well as ALG9, a
housekeeping gene whose expression does not change with AgNP treatment based on my RNAseq data. The genes FAF1 and SDA1 exhibited 2.88 ± 0.44-fold and 3.12 ± 0.53- fold
upregulation in gene expression with treatment of 5 μg/mL AgNPs, whereas DAN1 and TIR1
expression levels decrease more than 270-fold and 12-fold, respectively (Figure 5A&B).
Together, the results of gene fold change measurement with RT-qPCR are consistent with our
RNA-seq assay.
Determination of ROS in Cells Incubated with AgNPs. Several genes implicated in
mitochondrial functions are downregulated (Figure 4B and Table 3), and therefore, I wanted to
test levels of ROS originated from the mitochondria. To measure the total level of ROS from the
mitochondria I used DHR123, which enters the cell and is oxidized by ROS to form R123 and to
emit green fluorescence [76]. It was found that total levels of mitochondria-driven ROS in
response to up to 10 μg/mL of AgNPs was not changed when compared to the ROS level of nontreated groups or 5 μg/mL AgNP-treated groups (Figure 6A–D). Given that the concentration of
superoxide in cells with stress rises, I then determined levels of superoxide by using DHE, a
superoxide indicator emitting red fluorescence [77]. Interestingly, the data showed that levels of
superoxide in the presence of both 5 and 10 μg/mL of AgNP were decreased (Figure 6E–H). It is
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not clear why superoxide levels in cells with AgNPs decreases, but Jones et al. (2011) recently
proposed that cellular superoxide can be quenched in the presence of Ag ions derived from
AgNPs. Therefore, I concluded that the decrease of superoxide in AgNP-treated cells may be due
to ionized Ag reacting with superoxide in the cell [78].
Investigation of Cell Wall Integrity in Cells Incubated with AgNPs. I found several
genes involved in cell wall organization and genes that code for cell wall structural proteins, such
as manno-proteins, to be downregulated (Figure 4). I wanted to test the integrity of the cell wall
in yeast treated with varying concentrations of AgNPs. To investigate the stability of the cell
wall, I used an enzyme, Zymolase 100T, that creates spheroplasts and degrades the cell wall. It
was found that the rates of cell wall degradation in samples treated with Zymolase 100T were
much higher in samples treated with 10 μg/mL AgNPs than 5 μg/mL AgNPs and the same
relationship was observed between 5 μg/mL AgNPs and samples not treated with AgNPs (Figure
7). Therefore, I concluded that the rates of cell wall degradation of AgNP-treated cells are higher
than non-treated cells and the cell walls of AgNP-treated cells are less stable than their untreated
counterparts.

Discussion
There are increasing concerns for AgNPs’ potential environmental risks due to the fact
that AgNPs are widely used in many commercial products. However, the temporal resolution of
their effects on cellular and molecular dynamics is poorly understood. I elucidated the molecular
mechanisms of cytotoxicity caused by AgNPs in the budding yeast, S. cerevisiae, by
comprehensively investigating global mRNA expression patterns, and to my knowledge the
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Figure 1. Effects of silver nanoparticles on the viability of yeast. (A) Growth curves of wild-type
(S288C) cells grown in SD-Glu media containing different concentrations (0–10 μg/mL) of
silver nanoparticles. The graph was produced by measuring the optical density (OD) at 600 nm
of the solution once every 10 min for 24 h. Each plate contained four replicate experiments. Two
plates were tested. Each point on the curve is an average of eight experiments. (B) The maximum
OD at 600 nm of each test concentration of silver nanoparticles, with the background subtracted.
Control wells containing only media and silver are subtracted from each test well resulting in an
optical density reading indicative of cell concentration. (C) Average amount of time spent in lag
phase of cell cycle for each sample. (D) Doubling time of each concentration of silver
nanoparticles was found using the natural log of growth curves from (A) to determine the growth
rate, which was then used to calculate the doubling time. Each bar represents an average
doubling time of eight experiments.

41

Figure 2. FUN-1 stain to determine metabolic activity of AgNP-treated yeast cells. (A) Example
of a metabolically active yeast cell stained with FUN-1 (left). Example of a metabolically
inactive and presumably dead yeast cells treated with FUN-1 dye (right). (B) Control cells with
no AgNP treatment, cells treated with 5 μg/mL AgNPs and cells treated with 10 μg/mL AgNPs
after being incubated for 30 min with FUN-1. (C) Quantification of percentage of cells
considered metabolically active based on their successful transport of FUN-1 dye to the vacuole.
Table 1. Number of DEGs when exposed to 5 μg/mL AgNPs
Total number of genes
Not differentially
Number of DEGs (q <
found (including
expressed
0.05)
noncoding genes)
7126
5281
1845
Percent of total

74.11%

25.89%

Number of DEGs
(fold change ≥ 2.82)
196
2.75%

present study is the first RNA-seq report that indicates that a sub-lethal amount of AgNPs
negatively affects many cellular processes occurring in the budding yeast. Though the current
study does not illustrate differentially expressed genes, a recent study revealed a significant
overlap (13–21%) of differentially expressed genes among AgNO3- and AgNP-treated
Arabidopsis thaliana [79], indicating that this gene alteration in AgNP-treated groups was, at
least in part, originated from Ag ions released by AgNPs. In the future, it is of great interest to

42

identify differentially expressed genes shared (or distinctive) upon exposure to AgNPs and Ag
ions.

Figure 3. Differentially expressed genes with AgNPs. Differentially expressed genes with a qvalue lesser than 0.05 were analyzed to find Gene Ontology terms (GO-terms) that correspond
with each individual gene’s biological process. Out of 7126 total genes, 1845 were found to be
statistically significant. (A) The quantitation of upregulated genes associated with its specific GO
term(s). Of the 1845 statistically significant genes, 1077 are found to be upregulated. (B) The
quantification of downregulated genes associated with specific GO-terms. The other 768
statistically significant genes were found to be downregulated.
Upregulated mRNAs and their Potential Impacts on the Cell Integrity. I found more
than 80 genes out of 144 most upregulated genes upon 5 μg/mL treatment of AgNPs are
identified to function for rRNA processing/ribosome biogenesis. Many translated products of
these 80 genes locate at the nucleolus, associated with rRNA processing/ribosome biogenesis
(Figure 6A). For instance, genes coding for Enp2, Faf1 and its binding partner Krr1 [80] are
highly elevated in their expression with AgNP treatment. All of these proteins are synthesized in
the cytoplasm and then travel to the nucleolus to help with 18S rRNA processing, a component
of the small ribosomal subunit [80]. According to a previously published paper from Dr. Baserga
lab, Krr1 is a component of the small subunit (SSU) processome, a 2.2-MDa ribonucleoprotein
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complex involved in the processing, assembly and maturation of the SSU of the ribosome in
Eukaryotes [81]. Upon looking closely at the ‘rRNA processing’ and ‘ribosome small subunit
biogenesis’ rows in Table 2, I found 22 more upregulated genes that code for the known and
putative protein components of the yeast SSU processome: Nop1, Nop56, Nop58,

Figure 4. GO-term analysis of genes whose expression levels are significantly altered. A total of
144 most upregulated and downregulated genes with q-values less than 0.05 were analyzed and
matched with corresponding GO-terms to better illustrate the biological processes most affected.
(A) The quantification of the 144 most upregulated genes associated to their specific GO-term(s).
(B) The quantification of the 144 most downregulated genes associated to their specific GOterm(s).
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Imp4, Utp10, Utp13, Utp21, Rrp36, Utp11, Utp14, Noc4, Utp20, Utp23, Utp24, Bms1, Dbp8,
Dhr2, Rc1, Rok1, Rrp3, Rrp5, Enp1. The upregulated gene list (Table 2) also contains 39 genes
that code for assembly factors that function in maturation of 60S ribosomal subunit (or large
subunit [LSU] of ribosome) in S. cerevisiae [82], including Rrp5, Nop4, Urb1, Nop8, Mak21,
Noc2, Dbp3, Mak5, Ssf1, Mak16, Brx1, Rpf1, Ytm1, Erb1, Nop7, Drs1, Nop15, Nsa1, Rlp7,
Has1, Nop2, Rpf2, Rrs1, Rlp24, Nog1, Spb1, Nsa2, Nug1, Rix7, Rix1, Mdn1, Rsa1, Sda1, Rei1,
Yvh1, Mrt4, Puf6, Arx1 and Nmd3. Consistent with these upregulations of factors for SSU and
LSU of ribosome, a number of genes that code for RNA polymerase 1 holoenzyme were
upregulated upon AgNP treatment (See ‘transcription from RNA polymerase 1 promoter’
category of Table 2). Tying together, my observation is that sub lethal amounts of AgNPs in the
budding yeast stimulate ribosome biogenesis at the nucleolus (Figure 8A). A fundamental
question in relation to this observation is the potential cause of these upregulations. Previous
results from Escherichia coli–AgNP interaction studies can provide hints for interpreting the
RNA-seq data. It has been shown that AgNPs release Ag+ ions, which bind to thiol groups (SH)
of the protein [83, 84]. Furthermore, AgNPs were found to interact with ribosomes in a manner
similar to the binding mode suggested above, leading to denaturation or inactivation of ribosome
proteins and thereby resulting in inhibition of translation and protein synthesis [84-86]. By
interpolating the negative consequence of Ag+ binding to ribosomes into our RNA-seq results,
one can put forth the idea that Ag+ affects yeast ribosome functions negatively via temporal or
stable interactions with ribosomal components. In response to the signal of the presence of com
promised or inefficient ribosomes, the cell might stimulate de novo formation of healthy
ribosomes, for which the corresponding activities of SSU and LSU processosomes, rRNA
synthesis, tRNA synthesis (see Table 3 for upregulated genes implicated in tRNA processing)
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and ribosome export to the cytoplasm (Table 3) should be upregulated (see the model in Figure
8A).

Figure 5. Assessment of gene expression fold-change with RT-qPCR. Fold-change values of two
up and downregulated genes, which were identified by the RNA-seq experiments, were
compared to a housekeeping gene (ALG9) that was not be differentially expressed when treated
with AgNPs. Fold-change values were calculated with data obtained from RT-qPCR and the
Pfaffl equation. The fold changes found with RT-qPCR were done to validate RNA-seq data. (A)
The calculated fold changes of the upregulated genes FAF1 and SDA1. (B) The calculated fold
changes of the downregulated genes DAN1 and TIR1. Student’s t-test results are indicated either
∗∗ (P < 0.01) or ∗∗∗ (P < 0.001).
Downregulated mRNAs and their Potential Impacts on the Cell Integrity. It has been
well known that AgNPs display their antimicrobial potential through impairing biological
membranes. Ag+ ions released from the surface of AgNPs can bind to proteins carrying SO4 −,
causing irreversible structural alteration, which in turn disrupts cell membrane integrity [87, 88].
In agreement to this concept, a recent SEM (scanning electron microscopy) study with Candida
albicans revealed that yeasts with AgNPs 0.0089 ppm treatment for 1 day displayed a rough cell
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surface, indicating outer cell wall damage [89]. Their TEM (transmission electron microscopy)
data further displayed that the yeast cell wall treated with AgNPs was swollen thicker (nearly 2-

Table 2. GO term analysis with 144 most upregulated genes.
Gene Ontology
No. of
Corresponding genes
term
genes
BMS1, BMT5, BMT6, CGR1, DBP2, DBP3, DBP8,
DBP9, DHR2, DIM1, DRS1, EBP2, ECM16, EFG1,
ENP1, ENP2, ERB1, FAF1, FAL1, HAS1, HCA4, IMP4,
KRI1, KRR1, MAK16, MAK5, MDN1, MRD1, MRT4,
MTR4, NAN1, NIP7, NOC3, NOC4, NOG1, NOP1,
NOP12, NOP14, NOP2, NOP4, NOP56, NOP58, NOP7,
NOP8, NSA2, NSR1, NUG1, PRP43, PWP1, PWP2,
RCL1, REX4, RIX1, RLP7, RNT1, ROK1, RPF1, RPF2,
RRP12, RRP3, RRP36, RRP5, RRP8, RRS1, SAS10,
SPB1, SSF1, TSR1, TSR4, URB1, UTP10, UTP11,
UTP13, UTP14, UTP20, UTP21, UTP23, UTP4, UTP5,
UTP6, UTP8

rRNA processing

81

Ribosomal small
subunit biogenesis
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BMS1, DBP8, DHR2, DIM1, ECM16, EFG1, ENP1,
ENP2, FAF1, FAL1, HAS1, IMP4, KRE33, KRI1, KRR1,
LTV1, MRD1, NAN1, NOC4, NOP14, NOP58, NOP7,
NSR1, PRP43, PWP2, RCL1, ROK1, RRP12, RRP3,
RRP36, RRP5, RRS1, SAS10, TSR1, TSR4, UTP10,
UTP11, UTP13, UTP14, UTP20, UTP21, UTP23, UTP4,
UTP5, UTP6, UTP8

Ribosomal large
subunit biogenesis
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BRX1, DBP3, DBP9, DRS1, ERB1, HAS1,
MAK16, MAK21, MAK5, MDN1, MRT4, NIP7, NOC2,
NOG1, NOP12, NOP15, NOP2, NOP4, NOP7, NOP8,
NSA1, NSA2, NUG1, PRP43, PUF6, REI1, REX4, RIX1,
RIX7, RLP24, RLP7, RPF1, RPF2, RRP5, RRP8, RRS1,
RSA4, SDA1, SPB1, SSF1, SYO1, URB1, YTM1, YVH1

Nuclear transport

19

ARX1, ENP1, KAP123, LTV1, MTR4, NMD3, NOG1,
NOG2, NUG1, REI1, RIX1, RIX7, RPF1, RRS1, RTP1,
SDA1, SRP40, SYO1, UTP8

47

Table 2 Continued. GO term analysis with 144 most upregulated genes.

RNA modification

16

BMT5, BMT6, DIM1, DUS3, ELP3, GAR1, GCD10,
NOP1, NOP2, NOP56, PPM2, RRP8, SPB1, TRM1,
TRM11, TRM2

Ribosome assembly

15

BRX1, DRS1, MAK21, MDN1, MRD1, MRT4, NSR1,
REX4, RIX1, RPF1, RPF2, RRP5, RSA4, SSF1, YVH1

Organelle assembly

15

BRX1, DRS1, MAK21, MDN1, MRD1, MRT4, NSR1,
REX4, RIX1, RPF1, RPF2, RRP5, RSA4, SSF1, YVH1

Transcription from RNA
polymerase I promoter

11

NAN1, RPA135, RPA190, RPA34, RPA43, RPA49,
RRN11, UTP10, UTP4, UTP5, UTP8

Ribosomal subunit export
from nucleus

11

ARX1, LTV1, NMD3, NOG1, NOG2, NUG1, RIX1,
RIX7, RPF1, RRS1, SDA1

Biological process
unknown

10

CMS1, GFD2, IMD4, NOP13, NRP1, RRT14, YBL028C,
YCR016W, YDL050C, YPR123C

Signaling

2

EFG1, YVH1

Cytokinesis

1

NOP15

mRNA processing

1

PRP43

Cellular response to DNA
damage stimulus

1

TRM2

Vacuole organization

1

YVH1

Regulation of cell cycle

1

SDA1
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Table 2 Continued. GO term analysis with 144 most upregulated genes.
RNA splicing
Regulation of DNA
metabolic process

PRP43

1
1

RIX1

DNA-templated
transcription, initiation

1

RRN11

Sporulation

1

DNA-templated
transcription,
termination

1

DNA repair

1

Transmembrane
transport

1

Regulation of protein
modification process

1

YVH1
RNT1

TRM2

Proteolysis involved in
cellular protein
catabolic process

AGP1

FPR4

ACL4
1
KAP123

Pseudohyphal growth

Lipid metabolic
process

1
URA7
1
RBG1

Cytoplasmic
translation

1

Response to oxidative
stress

1

LTV1
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Table 2 Continued. GO term analysis with 144 most upregulated genes.

Cell budding

1

REI1

Meiotic cell cycle

1

YVH1

Amino acid transport

1

AGP1

Response to osmotic
stress

1

LTV1

Regulation of
translation

1

PUF6

Response to starvation

1

RBG1

fold increase in thickness) and was partially disruptive, consistent with the presence of holes and
pits on the cell wall of yeast treated with AgNPs [67]. Importantly, the RNA-seq results in
conjunction with GO term analysis provide a more comprehensive view of defects in cell wall
organization caused by AgNPs. First, it appears that AgNPs affect proper turnover rate of cell
wall components including mannoprotein and glycans. I postulate this idea because the
thickening of yeast cell wall upon treatment of AgNPs [89] might be due to either a unsteady
organization of the cell wall or an accumulation of cell wall proteins. The idea of destabilization
of the cell wall has been proven true [67], while the possibility of the accumulation of cell wall
mannoproteins and glucans in the presence of AgNPs has yet to be tested. Based on my RNAseq data, the following seven genes implicated in cell wall organization are highly
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downregulated: TIR1–4, DAN1, GSC2 and RNT1. These four TIR and DAN1 genes code for
cell wall mannoproteins, while the gene product of GSC2 is a catalytic subunit of β-1,3-glucan
synthase required for cell wall glucan synthesis and remodeling in S. cerevisiae [90]. RNT1 gene
is involved in cell wall stress response and in regulating degradation of cell wall integrity [91].
The significant reduction of these mRNA levels indicates the possibility that the cell senses an
abnormally thick cell wall caused by AgNPs. Even though the thicker wall does not necessarily
mean an increase in the number of manno-proteins and glucans, we cannot exclude the
possibility that the abnormality is, in part, due to an accumulation of these cell wall components.
In this scenario, genes for these cell wall components can be downregulated since the regulatory
factors for cell wall integrity would act against the expression of cell wall components (Figure
8B, model B).
In light of the finding of the downregulation of six ergosterol synthesis genes (Table 3),
including ERG11, 25, 28, 3, 5 and 6, one can conjecture that the integrity of the plasma
membrane is compromised in the presence of AgNPs. Consistent with this idea, genes for
membrane sugar transporters such as HXT13, HXT17 and HXT2 are differentially expressed
(Table 3 and Figure 8B, model B). Furthermore, multiple genes implicated in carbohydrate
metabolism in the cytoplasm (Figure 6, model B) were downregulated. The possibility is that
both destabilization of the plasma membrane and decreased levels of sugar transporters in
AgNP-treated samples limit the amount of sugar to be metabolized in the cytosol (Figure 8B,
model B). In addition to the metabolic defects, genes associated with pyruvate transport (MPC3),
TCA cycle (ACO1, CIT2, CIT3) and NADH regeneration (ALD4 and GUT2) were
downregulated with AgNPs (Table 3, and Figure 8B). Therefore, my observation is not only
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Table 3. Go term analysis with 144 most downregulated genes.
No. of
Gene Ontology term
Corresponding genes
genes
CMC4, ECM13, FMP23, HBN1, ICY1,
LEE1, MMO1, PBI1, RTS3, SNR190, TDA4,
TOS8, TBR012C, YBR056W-A, YBR201CA, TDR182W-A, YDR535C, YER121W,
YER188W, YFL051C, YGR035C,
YGR066C, YGR107W, YHL045W,
YHR033W, YHR210C, YJL213W, YJL215C,
YLR053C, YLR108C, YLR152C,
YLR342W-A, YML083C, YML131W,
YMR196W, YOR032W-A, YOR387C,
YOR392W

Biological process unknown

38

Lipid metabolic process

15

ATF2, CIT3, CYB5, ECI1, EEB1, ERG11,
ERG25, ERG28, ERG3, ERG5, ERG6,
PDH1, POT1, UPC2, YEH1

Transmembrane transport

12

AAC3, ADY2, BAP2, ENA1, HXT13, JEN1,
MPC3, PRM6, SCR1, STL1, SUL1, ZRT1

Transmembrane transport

12

Response to chemical

11

ATF2, CIN5, GRX6, MF(ALPHA)2, NRG2,
PRR2, TSA2, UPC2, VHR1, ZNF1, ZTA1

Monocarboxylic acid metabolic
process

11

ALD4, ALD6, CIT2, CIT3, DLD3, ECI1,
EEB1, FMS1, MLS1, PDH1, POT1

Ion transport

11

ADY2, ALP1, ATO2, BAP2, DIP5, ENA1,
JEN1, MPC3, PRM6, SUL1, ZRT1

Cell wall organization or
biogenesis

10

GIP1, GSC2, OSW2, SPO73, TIP1, TIR1,
TIR2, TIR3, TIR4, DAN1

AAC3, ADY2, BAP2, ENA1, HXT13, JEN1,
MPC3, PRM6, SCR1, STL1, SUL1, ZRT1
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Table 3 Continued. Go term analysis with 144 most downregulated genes.
Transcription from RNA
polymerase II promoter

CIN5, NRG2, PHD1, PRR2, ROX1, UPC2,
VHR1, YAP6, ZNF1

9

Ergosterol
biosynthesis/organization

8

HES1, ERG11, ERG25, ERG28, ERG3,
ERG5, ERG6, UPC2

Carbohydrate metabolic process

8

CIT2, GSC2, GUT2, IMA1, MAL32, MLS1,
PYC1, SUC2

Meiotic cell cycle

7

GIP1, GSC2, MPC54, MSH5, OSW2, SPO20,
SPO73

Transcription from RNA
polymerase II promoter

9

CIN5, NRG2, PHD1, PRR2, ROX1, UPC2,
VHR1, YAP6, ZNF1

Ergosterol
biosynthesis/organization

8

HES1, ERG11, ERG25, ERG28, ERG3,
ERG5, ERG6, UPC2

Carbohydrate metabolic process

8

CIT2, GSC2, GUT2, IMA1, MAL32, MLS1,
PYC1, SUC2

Meiotic cell cycle

7

GIP1, GSC2, MPC54, MSH5, OSW2, SPO20,
SPO73

Generation of precursor
metabolites and energy

6

AAC3, ACO1, ATF2, CIT3, ISF1, RGI2

Sporulation

6

GIP1, GSC2, MPC54, OSW2, SPO20, SPO73

Transposition

6

YBL005W-B, YBL100W-B, YBR012W-B,
YDR261W-B, YMR045C, YNL284C-B

Cofactor metabolic process

5

ALD4, ALD6, FMS1, GUT2, HEM13
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Table 3 Continued. Go term analysis with 144 most downregulated genes.
Response to osmotic stress

5

ALD6, CIN5, ENA1, NRG2, ROX1

Cellular respiration

4

AAC3, ACO1, CIT3, ISF1

Carbohydrate transport

4

HXT13, HXT17, HXT2, STL1

Cellular amino acid metabolic
process

4

BAT2, CAR2, CIT2, PUT1

rRNA processing

4

SNR10, SNR17A, SNR34, SNR37

Response to oxidative stress

4

GRX6, TSA2, VHR1, ZTA1

Vitamin metabolic process

3

RNA modification

3

SNR10, SNR34, SNR37

Oligosaccharide metabolic
process

3

IMA1, MAL32, SUC2

Membrane trafficking and
protein targeting

3

COS4, SCR1, SPL2

Amino acid transport

3

ALP1, BAP2, DIP5

Response to starvation

3

ENA1, UPC2, VHR1

Pseudohyphal growth

3

NRG2, PHD1, MIT1

FMS1, SNZ1, THI4
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Table 3 Continued. Go term analysis with 144 most downregulated genes.
Protein folding
2
EUG1, HSP26

Nucleobase-containing small
molecule metabolic process

2

ALD4, ALD6, GUT2

DNA repair/recombination

2

IRC4, MSH5

mRNA processing

2

AI1, SNR19

Mitochondrion organization

2

ACO1, THI4

Mitochondrial translation

2

15S˙RRNA, 21S RRNA

Ribosomal small subunit
biogenesis

2

SNR10, SNR17A

Conjugation

2

Enzyme

2

Cellular response to DNA
damage stimulus

1

Translational elongation

1

Protein dephosphorylation

1

Protein phosphorylation

1

Invasive growth in response to
glucose limitation

1

MF(ALPHA)2, PRR2
ERR3, MAN2
IRC4
ANB1
GIP1
PRR2

NRG2
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Table 3 Continued. Go term analysis with 144 most downregulated genes.
Signaling
1
MF(ALPHA)2

consistent with previous findings that demonstrated that nano-silver particles cause direct
mitochondrial damage, disturb the function of respiratory chain, increase ROS production and
induce apoptosis [92-94], but also provide new mechanistic insights into mitochondrial
dysfunction mediated by AgNPs.

Figure 6. Assessment of ROS and superoxide levels in flow cytometry experiments. Two
mitochondrial ROS indicators, DHR123 and DHE, were utilized in the quantification of ROS
and superoxide in yeast cells treated with varying concentrations of 20 nm AgNPs for 8 h.
DHR123 and DHE were added at concentrations of 5 μg/mL for the last 2 h of incubation. Each
treatment concentration (0, 5 and 10 μg/mL of AgNPs) was tested in triplicate. A two-tailed
equal variance Student’s t-test was performed, and no statistical difference was observed
between the three groups. (A–C) Representative DHR123 fluorescent intensity charts of cells
treated with DHR123 and grown in the presence of no AgNPs (A), 5 μg/mL AgNPs (B) or 10
μg/mL AgNPs. (D) Quantification of DHR123 levels. The total % fluorescence means from each
replicate in the ROS detection assay. (E-G) Representative DHE fluorescent intensity charts of
cells treated with DHE and grown in the presence of no AgNPs (E), 5 μg/mL AgNPs (F) or 10
μg/mL AgNPs (G). (H) The total % fluorescence means from each replicate in the superoxide
detection assay.
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Additionally, a recent study with S. cerevisiae where 9 nm AgNPs were used showed that
5 or 10 μg/mL of AgNPs caused a drastic inhibition of cellular respiration taking place in
mitochondria [95], augmenting the notion that mitochondrial functions are downregulated.
Consistently, the present study shows downregulation of AAC3, a ADP/ATP translocator gene
functioning for exchanging ADP generated by the F1F0-ATPase for ATP (Table 3, not shown in
Figure 8B) [96, 97]. It is highly likely that low levels ADP in the mitochondrial matrix due to
downregulation of AAC3 by AGNPs limit the substrate concentration for the ATP synthase,
which may limit the amount of ATP production. Yet to maintain cell viability, the limited
amount of ATP must be

Figure 7. Assessment of cell wall stability with Zymolase 100T enzyme. The rate of yeast cell
wall degradation was observed in samples treated with 0, 5 and 10 μg/mL AgNPs, and each
sample was tested in triplicate. When treated with Zymolase 100T, the OD’s of each sample was
recorded every 10 min for 6 h. The rate of cell wall degradation mediated by Zymolase 100T
indicates the integrity of cell walls when incubated with varying concentrations of AgNPs. The
empty circles represent the mean of the samples treated with no Zymolase 100T. The solid black
squares represent the mean of the samples treated with 0 μg/mL AgNPs and 10 μg/mL Zymolase
100T. The empty diamonds represent the mean of the samples treated with 5 μg/mL AgNPs and
10 μg/mL Zymolase 100T. The solid black triangles represent the mean of the samples treated
with 10 μg/mL AgNPs and 10 μg/mL Zymolase 100T.
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Figure 8. Schematic model of changes of cellular processes with spherical 20 nm AgNPs in
yeast cells. (A) AgNPs appear to affect the integrity of ribosome, which might end up elevating
expression levels of genes implicated in rRNA processing and the biogenesis of small large
subunit ribosomes as well as nuclear export of ribosomes. (B) Several classes of cellular
activities appear to be downregulated by the presence of AgNPs, including cell wall/membrane
integrity, sugar import, metabolism in the cytosol, cellular respiration in mitochondria and
protein folding.
Conclusion
In the present study, I assessed potential toxicity of AgNPs and provided evidence that
yeast cells exposed to these NPs displayed minor defect in growth rates. Accordingly, the
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presence of 5 μg/mL AgNPs in the culture media led to significant transcriptome changes in
yeast, manifested by the differential expression of several hundred genes implicated in diverse
cellular processes. Given many genes that play roles in ribosome biogenesis, cell wall/membrane
integrity and mitochondrial functions are significantly altered with the treatment of AgNPs, my
conclusion is that even sublethal amounts of AgNPs could serve as a potential environmental
stress factor to living cells.
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CHAPTER 3: TRANSCRIPTOME PROFILE ALTERATION WITH CADMIUM
SELENIDE/ZINC SULFIDE QUANTUM DOTS IN SACCHAROMYCES CEREVISIAE

Introduction
Quantum Dots (QDs) are extremely small colloidal semiconductor nanoparticles (NPs)
typically 1–10 nanometers in diameter. They are a diverse group of nanomaterials (NMs) that are
classified based on physical properties, such as their size, charge, shape, and the chemical
composition of their core and shell [11]. These materials (typically Cd-QDs) are an attractive
topic in research due to their unusual optical characteristics, mainly, their photo-stability,
narrow-tunable emissions, and broad excitation ranges [16, 18]. They have become widely
incorporated in electronics, agriculture, and textile production, but they are mostly sought out for
their biomedical applications (cellular and protein labels, real-time trackers, fluorescence
resonance energy transfer (FRET) sensors, etc.) and used as a smart drug delivery system
(SDDS) for treating cancer [11, 15-17, 19, 98, 99]. They make excellent fluorescent probes
because their optical properties are size-dependent and are easily manipulated. In addition, they
resist photo-bleaching and produce a greater brightness than conventional organic dyes [16, 17].
QDs make a prime candidate for use as nanocarriers in SDDSs because, unlike other
nanocarriers, they can simultaneously visualize tumors in addition to delivering a drug to its
target [15]. Although QDs are diverse and utilized in numerous applications, there is an
increasing concern on their leakage and long-term effects on the environment and human health
[11, 19].
Previously published works on QDs present conflicting results regarding cytotoxicity, but
most articles that investigate their effects, in vitro and in vivo, seem to agree that their
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physiochemical properties, such as size, charge, composition, and concentration, are responsible
for their toxicity [18, 100]. Herein lies the challenge of studying QD toxicity. Their high possible
combinations of physiochemical properties result in a broader spectrum of toxic effects. It’s been
reported that small 2.2 nm CdTe-QDs localize in the nuclear compartment, and the same QDs at
5.2 nm localize in the cytosol [100]. Negatively charged zwitterionic QDs with functionalized
surfaces reduce mitochondrial activity by up to 25%, and cellular impedance is reported due to
receptor-independent entry through the membrane [17]. However, positively charged CdSe/ZnSQDs have been found to be less toxic [16]. CdTe-QDs exhibit a dose-dependent cytotoxic effect
on cell viability, membrane integrity, metabolic activity, mitochondria integrity, and chromatin
quality in an array of cells (HeLa, MCF-7, and NIH/3T3) [101]. The potential number of
interactions between QDs and biological components are high, leaving essential questions
regarding their toxicity unknown [16].
Previous studies have revealed that long-term exposure of 20 nM CdSe/ZnS-QDs, coated
with polyethylene glycol (PEG), amines, or carboxylates, to the eye results in decreased cell
viability [102]. Another study found that injecting 0.5 nM CdSe or CdSe/ZnS-QDs into the
hippocampal area in rats impairs synaptic activity. This was thought to be induced by increasing
calcium levels and Cd2+ ions that lead to defects in neuro-secretion [103, 104]. In addition, they
have been found to accumulate in the liver and kidneys in rats and could release Cd 2+ ions in the
body of the individual being exposed [105]. On the cellular level, CdSe/ZnS-QDs can enter the
cell through the plasma membrane and have been found to inhibit viability in macrophage [106,
107], human keratinocyte HaCaT [108], and human dermal fibroblast cell lines exposed to 15 nm
QDs at concentrations of 30–60 nM [109]. Previous studies have found that the degradation of
Cd-based QDs releases harmful Cd2+ ions that indirectly increase ROS levels (typically H2O2,
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·O2−, and ·OH), capable of damaging proteins and membrane lipids, inhibiting DNA repair,
disrupting cellular signaling, and causing apoptosis [110-113]. In addition, the precipitation of
QD aggregates on the surface of the cell may impair the integrity of the cell wall [111]. In yeast,
CdTe-QDs have been shown to exhibit cytotoxicity at concentrations as low as 80.81 and 17.07
nmol/L for green and orange emitting QDs, respectively [114]. Xiaole Han et al. revealed that
QDs as small as 4.1 to 5.8 nm could be internalized in Saccharomyces cerevisiae and induce
cytotoxicity through cell wall breakage and cytoplasm blebbing. Nevertheless, the details on
what molecular mechanisms contribute to Cd-based QD toxicity are still poorly understood. To
this end, my RNA-seq revealed more in-depth information on the processes and mechanisms that
might be responsible for Cd-QD-induced toxicity.
Research papers investigating QD toxicity typically look at mechanisms, such as cell
viability and induction of reactive oxygen species [16]. Gene expression assays are not common
in studies on Cd-QD-induced toxicity. Using high-throughput quantitative reverse transcript
polymerase chain reaction (qRT-PCR) assays, recent studies reported differentially expressed
genes affected by CdSe/ZnS-QD toxicity, including genes involved in cellular stress and toxicity,
DNA damage and repair, mitochondrial function, proliferation, and ovarian function in vivo [16,
115, 116]. RNA-seq has become the standard for assessing entire genomes and identifying
differentially expressed genes (DEGs), and Simon et al. (2013) utilized this process to
investigate the effects on transcriptomic profiles of green algae exposed to CdTe/CdS-QDs. They
reported via a gene ontology (GO) analysis that DEGs were involved in oxidative-stress, redox
potential, protein folding, and chaperone activity pathways in the Cd-treated cells [27]. Hosiner
et al. (2014) conducted a microarray experiment on Saccharomyces cerevisiae that was exposed
to several different metal salts to observe the effects of different metal ions on yeast’s
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transcriptional profile [23]. Their study revealed anti-oxidative genes (GRX2) and redox
homeostasis genes (TRR1, TRR2, and TRX2) to be upregulated in response to CdCl2 exposure,
due to potential release of Cd2+ ions [23]. Interestingly, cadmium is not redox-active, which
means it cannot generate ROS directly, yet, Cd-induced ROS is a commonly observed response
[117]. They pointed out that metals, such as As3+, Cd2+, and Hg2+, had an affinity toward thiol
groups (-SH), which play disparate roles in the function of enzymes, transcription factors, and
membrane proteins [23]. A more recent study conducted in 2016 employed RNA-seq to assess
differences in gene expression when exposed to 320 μM CdSO4 in Saccharomyces
cerevisiae [117]. They sorted DEGs into functional classes and found upregulated DEGs
belonged to classes, such as transcription factors involved in GSH metabolism, proteins of
cellular response to oxidative stress and regulation, enzymes of carbohydrate metabolism,
proteins with antioxidant properties, mitochondrion related proteins, peroxisome, and other
regulator/transcription factors, while downregulated DEGs belonged to a class of normal
expression genes under anaerobic condition (DAN1, AAC3, ANB1, and YER188W) and heme
biosynthesis key genes (HEM3 and HEM13). In addition, their study revealed that
CdSO4 decreased the mitochondrial membrane potential by over 52% and significantly increased
ROS levels [113]. However, little is still understood on the transcriptional profiles
of Saccharomyces cerevisiae when treated with a non-ionizing, Cd-based QD (CdSe/ZnS) that
possesses a ZnS shell meant to prevent any harmful Cd2+ from leaking out of the CdSe core.
Though CdSe/ZnS-QDs have been used in many ways and conjugated or coated with
various molecules and exposed to a variety of organisms, their impact on cellular environments
and gene expression is not well understood and raises concerns about their potential toxicity,
despite their “safe” core/shell structure. Chibli et al. found other “safer” core/shell QDs, such as
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InP/ZnS-QDs, generating ROS despite their ZnS shell [118]. Their study attributed the
generation of ROS in NIH3T3 fibroblasts, KB cells, B16 murine melanoma cells, and MDAMB-231 breast adenocarcinoma cells to the poor coordination strength between the InP core and
ZnS shell, resulting in an unstable core/shell relationship that left the InP core exposed in some
areas [118]. With the addition of a second ZnS shell around InP/ZnS-QDs, exposed sections of
the core were contained, and a decrease in ROS generation was observed [118]. It was noted that
a CdSe core and ZnS shell had a better coordination strength, resulting in a stable core/shell
structure with minimum CdSe core exposure [118]. Due to these interesting results, it is unlikely
that CdSe/ZnS-QDs require a second ZnS shell for their safe use. In addition, the CdSe/ZnS-QDs
were synthesized with a carboxylic acid stabilizing ligand that is capped on the surface on the
ZnS shell. Capping ligands are often used to prevent QDs from aggregating, and some may play
a major role in the uptake of QDs into cells and where they are localized. Kunstman and
associates (2018) bio-conjugated CdTeS/ZnS-QDs with a galactose ligand and successfully
achieved fluorescent imaging of yeast cells [119]. They revealed that CdTeS/ZnS-QDs capped
with galactose ligands accumulated in the membrane of yeast cells, while CdTeS/ZnS-QDs with
unmodified surfaces failed to accumulate in the membrane or enter the yeast cells, suggesting
that specific associations between the ligands and cell surface may play a role in the entry of CdQDs into yeast cells [119]. Due to CdSe/ZnS-QDs seemingly more stable structure than other
core/shell QDs, their effects on cell physiology have remained elusive and require further
explanation. The present study utilized deep sequencing technologies like RNA-seq to assess to
what extent CdSe/ZnS-QDs affect the transcriptome profile of Saccharomyces cerevisiae with
great precision.
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Results
CdSe/ZnS-QDs Negatively Affect Yeast Growth. To investigate the effects of
CdSe/ZnS-QDs on yeast growth, I utilized AgNPs as a positive control, as they have been shown
to cause growth defects in yeast cells by Horstmann and coworkers [47]. As expected, the
treatments of AgNPs obtained results consistent with the findings of Horstmann and coworkers,
where the concentrations of 5 µg/mL and 10 µg/mL of AgNPs showed significant growth rate
reduction when compared to non-treated controls (Figure 9A,B). In contrast, CdSe/ZnS-QDs did
not show any effects on yeast growth when compared to the non-treated controls, even when
treated with 100 µg/mL of CdSe/ZnS (Figure 9A,B). In order to more clearly define the
differences of cell growth in the steady-state, I analyzed the last optical density value (endpoint
OD600 nm at 24 h) for both the AgNPs and CdSe/ZnS-QD-treated cells. In the CdSe/ZnS, there
was no significant difference in endpoint OD values compared to the non-treated control
according to the ANOVA test (Figure 9C,D). Similarly, the endpoint OD of AgNPs showed no
significant difference from the non-treated control, via an ANOVA test (Figure 9C,D). However,
when performing a student t-test on ODs exposed to both AgNP and CdSe/ZnS-QDs, the results
revealed the endpoint ODs were statistically different from those of the non-treated control in
cells treated with 5 µg/mL AgNPs (20 nm) and 6.25 µg/mL CdSe/ZnS-QDs (estimated 4.1 nm).
During the exponential growth period, I analyzed the difference in doubling times between the
non-treated controls and the treated cells. For the CdSe/ZnS-treated cells, the student t-test
revealed that the average time spent in exponential growth was not significantly different from
the non-treated control. As for the AgNP-treated cells, the average doubling time was
significantly different from the non-treated control for most of the concentrations, according to
the student t-test. Before the cells grew exponentially, the cells treated with either AgNPs or
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Figure 9. Growth assay to determine growth rates of CdSe/ZnS and AgNP-treated yeast cells.
(A,B) Quantification of cell optical densities over a 24 h period, where the cells were treated
with CdSe/ZnS and AgNPs, respectively, at 30 °C while shaking. (C,D) Measurement of cell
optical densities at 24 h of treatment with CdSe/ZnS and AgNPs, respectively. The bar represents
the average ODs (600 nm) of each concentration at the 24 h mark. Significant statistical
differences are indicated by p-values less than 0.05. (E,F). Doubling time takes place during the
phase of exponential growth for the cells treated with CdSe/ZnS and AgNPs, respectively, and
was measured as the amount of time it takes for cells to double their ODs. p-values of less than
0.05 indicate statistical differences with an asterisk. (G,H). The mean lag time before the
exponential growth phase. AgNP, silver nanoparticle; OD, optical density.
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CdSe/ZnS-QDs showed, based on the student t-test, no significant difference from the nontreated controls. Taken together, based on the results obtained from the endpoint ODs, doubling
times, and lag times, CdSe/ZnS did not have any negative growth effects on yeast cell growth,
whereas the AgNPs showed adverse effects on yeast cell growth.
cDNA Sequencing Reveals Up- and Downregulated Genes with CdSe/ZnS-QDs.
Instead of relying on the limited simple methods of proliferation, organelle integrity, or
metabolic assays to gain insight on how CdSe/ZnS QDs interact with fungal cells, I decided to
look into differential gene expression profiles to examine a broader range of cellular processes
being affected. I determined the transcriptomic response in S. cerevisiae exposed to 10 μg/mL
CdSe/ZnS-QDs by performing an RNA-seq that produced gene expression profiles for both the
control and CdSe/ZnS-treated cells. Briefly, the control and CdSe/ZnS exposed cells were
subjected to a total RNA extraction. Then, the mRNA was isolated from the total RNA, followed
by a cDNA conversion step. Both control and QD-treated samples were tested in triplicate, and
the newly synthesized cDNA libraries were sequenced with a next-gen DNA sequencer
(Illumina®, San Diego, CA, USA) that produced sequenced datasets for each replicate. Each
cDNA dataset had to be uploaded to a computational data analysis platform (usegalaxy.org) for
processing, and all control and CdSe/ZnS-treated replicates were concatenated, leaving the first
dataset composed of the three control samples and the second of the QD-treated samples. Every
cDNA fragment underwent a quality check (FastQC) and quality trimming (FASTQ Quality
Trimmer) before being mapped to the reference genome (S288C). An average of 19,619,921
accepted reads was gathered from the control groups and 19,205,868 from the CdSe/ZnS-treated
groups. Of these quality reads, an average of 91.7% and 93.6% of the total reads mapped to the
reference genome, and an average of 9.9% and 10% of the mapped reads had multiple
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alignments in control and CdSe/ZnS-treated groups, respectively. The high percent of mapped
reads indicated that the cDNA sequence data accurately corresponded to the transcriptional
expression in S. cerevisiae, and the multiple sequence alignments indicated the successful
alignment of the fragmented sequence data to their homologous segments on the reference
genome. The gene identities were also accurately identified.
A total of 7127 genes, including non-coding cDNA, were identified, and of those, 4478
genes were found to have significant changes in transcript expression (q < 0.05) when compared
to the non-treated controls. From the pool of genes with q-values below 0.05, 2267 genes were
found to be upregulated, and 2211 genes downregulated. From each pool of up and
downregulated genes found to be significantly different, those differentially expressed by a fold
of 1.5 or greater were selected (2839 genes). From the gene pool of DEGs with a fold-change of
1.5 and up, I obtained GO terms with GOrilla and found 47.6% (742 of 1560 genes) of
upregulated genes involved in cellular nitrogen compound metabolic processes (Figure 10A).
Several upregulated genes were implicated in non-coding RNA (ncRNA) processing (18.7%),
rRNA processing (14.6%), translation (13.2%), ribonucleoprotein complex biogenesis (13.2%),
and cell cycle process (11.6%) (Figure 2A). For the above GO terms, 291 and 228 upregulated
genes were involved in ncRNA and rRNA processes, respectively (Figure 10A). Additionally,
206, 206, and 181 genes were implicated in translation, ribonucleoprotein complex biogenesis,
and cell cycle processes, respectively (Figure 10A). Enrichment values for GO terms found with
genes with a fold-change of 1.5 or greater fell between 1.0 and 2.0, meaning each GO-term was
approximately as meaningful as any other GO term shown. To gain a clearer understanding of
the changes in the cellular transcriptome after treating with CdSe/ZnS-QDs, I selected the 150
most upregulated and 150 most downregulated genes, i.e., 300 genes total, and obtained GO-
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term data consistent with my data represented. I also created a heatmap of these 300 genes to
visually depict their highly up- and downregulated expression levels compared to the non-treated
controls. I found 102/150 (68%) of these upregulated genes to be involved in cellular component
organization or biogenesis, such as ribosomal subunit biogenesis and its assembly to form
functional ribosomes. Several of the other highly upregulated genes were involved in ribosomal
RNA metabolic processes (63.33%), cleavage involved in rRNA processing (18%), maturation
of LSU (large subunit of ribosome, 12.66%) and SSU rRNA (small subunit of ribosome,
18.66%), ncRNA transcription (6%), macromolecule methylation (6%), and genes involved in
cell cycle DNA replication (2.66%). Of the 21 GO-terms, five GO-terms described the
maturation of rRNA, four GO-terms were involved in pre-ribosome biogenesis or assembly, four
GO-terms involved in transcription of rRNA by RNA polymerase I, and three GO-terms
involved in the transport and export of RNA and ribosomal subunits.
GO-term analysis on the downregulated genes with a fold difference of at least 1.5
indicated that metabolic processes were negatively affected (Figure 10B). Most downregulated
genes were implicated in small molecule metabolic (16.5%) and oxidation-reduction processes
(13.0%) (Figure 10B). Several more downregulated genes were involved in carbohydrate
metabolic processing (8.0%), responding to chemicals (7.5%), proteolysis (7.5%), ion
transmembrane transport (5.7%), import into the cell (3.9%), and the electron transport chain
(2.6%) (Figure 10B). For the downregulated GO-terms, 211 and 166 genes were implicated in
small molecule metabolic and oxidation-reduction processes, respectively (Figure 10B). In
addition, 102, 96, 96, 73, 50, and 33 genes were involved in carbohydrate metabolism, response
to chemicals, proteolysis, ion transmembrane transport, import into cell, and the electron
transport chain, respectively (Figure 10B). Enrichment values for GO-terms found with genes
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Figure 10. Differentially expressed genes with CdSe/ZnS QDs. GO-terms corresponding to each
differentially expressed gene’s biological process. Out of 4478 genes with a q-value below 0.05,
2839 genes with a fold change greater than or equal to 1.5 were incorporated. (A) The
quantification of upregulated genes associated with their specific GO terms. Of the 2839
statistically different genes, 1560 were found to be upregulated. (B) The quantification of
downregulated genes associated with their specific GO terms. Of the 2839 genes, 1279 were
found to be downregulated.
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with a fold-change of 1.5 or greater fell between 1.0 and 2.0, meaning each GO-term was
approximately as meaningful as any other GO-term shown. From the list of 150 most
downregulated genes, I found 26 GO-terms on their cellular processes compared to only 21 GOterms pertaining to the pool of 150 most upregulated genes. The downregulated GO-terms were
found to affect genes involved in various metabolic processes and were more diverse in the
cellular processes they effect compared to the upregulated GO-terms that are predominantly
involved in ribosomal biogenesis (Figure 10A,B). The GO-term with the most highly
downregulated genes from the list of 150 was the oxidation-reduction process with 31/150
(20.66%) genes involved. Other highly downregulated genes and their GO-terms given, based on
their cellular processes, were included but not limited to the Generation of precursor metabolites
and energy (18%), carbohydrate metabolic processes (16%), cellular response to chemical
stimulus (9.33%), alcohol metabolic process (5.33%), antibiotic metabolic process (6%),
response to drug (4%), and response to salt stress (3.33%). Of the 21 GO terms involved in
highly downregulated gene pool, 14 were directly involved in metabolism, four GO terms acted
as a response to stimuli, such as chemical stimulus, oxidative stress, drug, and salt stress, and
three GO terms were found to be directly involved in oxidation processes. I found many GO
terms involved in similar processes and several that share many of the same genes and several
that do not. For instance, of the four GO terms that represented genes that were involved in
responding to stimulus (cellular response to chemical stimulus, response to oxidative stress,
response to drug, and response to salt stress), the gene CTT1 was involved in each except in the
GO term response to chemical stimulus. Interestingly, NCE103 was found to be involved in the
GO terms response to chemical stimulus and oxidative stress, but not in the GO terms response
to drug or salt stress. Similarly, CIN5 was involved in the GO terms response to drug and salt
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stress but not in the GO terms response to chemical stimulus and oxidative stress. Some GO
terms that represent metabolic processes contained the exact same genes, such as the GO terms
ethanol metabolic process (four genes involved: PDC6, ALD4, ALD6, and NDE2) and alcohol
metabolic process (eight genes involved: DSF1, PDC6, ALD4, GUT2, YNR073C, YAT2, ALD6,
and NDE2). Likewise, there were GO terms that represent metabolic processes that had no genes
in common, such as the GO terms polysaccharide metabolic process (10 genes involved:
YMR084W, GSY1, GLC3, GIP2, GPH1, PGM2, GAC1, GDB1, UGP1, and SUC2) and antibiotic
metabolic process (nine genes involved: CTT1, TSA2, PDC6,
ALD4, ACH1, ALD6, NDE2, SDH1, and SHH4).
Validation of RNA-Seq Data by RT-qPCR. I validated my differentially expressed
gene data and expression profiles generated from the RNA-seq experiment by conducting a realtime RT-qPCR test. I selected two upregulated genes (FAF1 and SDA1) that play a role in rRNA
processing/ribosomal biogenesis, two downregulated genes (DAN1 and TIR1) that form
structural mannoproteins that help maintain cell wall integrity, and a housekeeping gene (ALG9)
whose expression is unchanged in the presence of CdSe/ZnS QDs, based on the RNA-seq foldchange data with a q-value less than 0.05. FAF1 and SDA1 were found to have 7.32 ± 0.52-fold
and 8.06 ± 2.15-fold upregulation in expression, and DAN1 and TIR1 were found to have 5.3fold and 3.3-fold downregulation in expression, respectively, when treated with 10 μg/mL
CdSe/ZnS-QDs (Figure 11A,B). The resulting fold-changes for FAF1, SDA1, DAN1, and
TIR1 were measured with RT-qPCR and graphed along with each gene fold-change found with
RNA-seq. A linear regression line was drawn to represent the correlation between the foldchanges found with each method, and the RT-qPCR fold-changes were found to be consistent
with my RNA-seq expression data (Figure 11C).
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Figure 11. Fold-change values acquired through RT-qPCR. Two up and downregulated genes
chosen from the RNA-seq experiments were compared to a housekeeping gene (ALG9) found to
not be differentially expressed when exposed to CdSe/ZnS-QDs. The fold changes of the two up
and downregulated genes were calculated from the RT-qPCR data by utilizing the Pfaffl
equation. Fold changes were found with RT-qPCR to validate fold-changes obtained with the
RNA-seq. (A) The fold changes of the upregulated genes (FAF1 and SDA1) obtained with RTqPCR. (B) The fold-changes of the downregulated genes (DAN1 and TIR1) obtained with RTqPCR. A student’s t-test results are represented with * (p < 0.05), ** (p < 0.01). (C) The fold
change correlation represented by a trend line that shows the power regression line with the
equation and R2 value of 0.94501. The x and y-axes are in 2- base logarithmic scale, and foldchanges that are <1 and >1 correspond to down and upregulation, respectively.
ROS in Response to CdSe/ZnS. It is known that cells respond to environmental factors,
including nanoparticles, by producing reactive oxygen species that affect the physiology of the
cells. To assess the amounts of superoxides produced by the cell when treated with CdSe/ZnS
(20 µg/mL) or AgNPs (5 µg/mL), I measured the fluorescent intensities of dihydroethidium
(DHE) at 600 nm using a flow cytometer. The rationale for measuring the DHE at 600 nm was to
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detect the amount of red fluorescence emitted by the oxidation of DHE that is caused by
superoxide. The no-cell controls, including only PBS, AgNPs, or CdSe/ZnS-QDs, displayed a
little background noise, which was manifested from their low cell counts, along with missing
DHE fluorescent intensity peaks (Figure 12A–C). However, the non-treated cell control sample
revealed a peak of cells that have oxidized DHE, along with a bigger peak that represents cells
carrying non-oxidized DHE. I found that the fluorescent intensities of the oxidized DHE in the
AgNP- and CdSe/ZnS-treated cells were not statistically different from that of the non-treated
cell control (Figure 12D–G). This suggests that both AgNPs and CdSe/ZnS-QDs have no
significant effect on the production of superoxide in the cells.
The Vulnerability of Cell Wall Integrity in Yeast Cells. Yeast cells maintain a cell
wall, which allows the cell to stay well protected from many threats across the board. However,
when treated with Zymolase, the cell wall breaks down and leaves the cell with only its plasma
membrane, making the cells more sensitive to environmental factors. It is known that
nanomaterials are coated with a diverse number of materials, such as sodium citrate coatings on
AgNPs and zinc sulfide coatings on CdSe, to minimize their toxicities. Based on the observations
made in the previous section (Figure 9), where CdSe/ZnS did not show any significant effects on
yeast cell viability, I was interested in observing what effects AgNPs and CdSe/ZnS would have
on sensitized yeast cells without cell walls. The no-cell control (Figure 13A) showed that the
AgNPs and CdSe/ZnS-QDs induced no change in the optical densities, ensuring that any
decrease in optical density during the cell cultures treated with the nanomaterials might be due to
cell death with adverse effects by the nanomaterials. The cells compromised by Zymolase
showed a modest decrease in cell density over time in the presence of CdSe/ZnS-QDs (20
µg/mL) when compared to the non-treated control, whereas the cells that were not treated with
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Figure 12. Quantitation of the levels of superoxide produced by cells treated with AgNP- or
CdSe/ZnS-treated samples. The cells were cultured for six hours with the nanomaterials, then
cultured for 2 h with DHE (dihydroethidium) prior to the measurement of the amount of oxidized
DHE, which indicates the levels of superoxide produced. (A) Non-treated cell control with only
PBS and DHE; minimal background noise was detected. (B) Non-treated cell control with only
AgNPs and DHE in PBS; a slight increase in background noise compared to PBS and DHE
alone. (C) Non-treated cell control with only CdSe/ZnS and DHE in PBS (the highest
background shows a fluorescent intensity detected at 103). (D) Non-treated control with cells
with DHE in PBS. The major peak indicates the number of cells carrying non-oxidized DHE,
while the small peak at fluorescent intensity 104.5 represents the number of cells carrying DHE
oxidized by the superoxide produced. (E) The effects of AgNPs (5 µg/mL) on the production of
superoxide, utilizing a similar method to Figure 4D. (F) The effects of CdSe/ZnS (20 µg/mL) on
the production of superoxide in cells is indicated by the second peak, as explained in Figure 4.
(G) Comparison of the percentage of cells that carry oxidized DHE in the non-treated control,
AgNPs (5 µg/mL)-treated cells, and CdSe/ZnS (20 µg/mL)-treated cells. Each bar in the graph
represents the average of three data sets, and this graph is one representation of three repeated
experiments.
Zymolase showed no significant changes in cell density over time (Figure 13B). Similarly, the
AgNPs caused cell density decrease in the presence of Zymolase, at higher concentrations than 5
µg/mL (Figure 13C). The rate of density decrease was more pronounced in the presence of
AgNPs than CdSe/ZnS-QDs, and therefore I re-plotted the cell density curves of Zymolasetreated cells from both Figure 13B,C. As a result, I observed that the CdSe/ZnS-treated cells (20
µg/mL) with Zymolase displayed less vulnerability to a decrease in cell density than AgNPtreated cells (5 µg/mL) with Zymolase. This suggests that the cell wall plays a major role in
preventing cell death caused by nanomaterials. In this sense, the AgNP-mediated growth defects,
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shown in Figure 9, appeared to be due to growth delay rather than cell death in the presence of
AgNPs. Further, without the presence of the cell wall, both AgNP and CdSe/ZnS-treated cells
showed sensitivity to cell death, although in varying degrees.

Figure 13. Cell wall viability assay to determine the effects of AgNPs or CdSe/ZnS-QDs on
yeast cells lacking cell walls via Zymolase treatment. (A) The optical densities of the
nanomaterials in TE buffer without yeast cells were measured at a wavelength of 594 nm for four
hours while shaking at 30 °C. (B) The cell density of yeast cells when treated with differing
concentrations of CdSe/ZnS (10 and 20 µg/mL), with or without Zymolase (non-Zymolasetreated cells did not show a significant change in optical density over time). (C) Cell density
measurements of yeast cells when treated with different concentrations of AgNPs (2.5 and 5
µg/mL), with or without Zymolase. (D) Rearrangement of optical densities from Zymolasetreated cells in Figure 5B,C. The non-treated control with Zymolase (filled circle) was compared
with 2.5 (empty triangle) and 5 (X symbol) µg/mL AgNP-treated cells, and 10 (empty square)
and 20 (filled triangle) µg/mL CdSe/ZnS-treated cells.
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Discussion
In August of 2017, the Environmental Protection Agency (EPA) enacted an “Information
Gathering Rule”, which requires companies that manufacture or process nanomaterials, regarded
as chemical substances, currently in commerce to inform them of the nanomaterials specific
chemical identity, production volume, methods of manufacture, processing, use, exposure and
release information, and available health and safety data. According to epa.gov, they are
attempting to facilitate innovation while ensuring the safety of the nanoscale substances but also
states that the information collected on the nanomaterial is not intended to conclude that
nanomaterials will cause harmful effects to human health or the environment. The EPA claims
that the information gathered is to be used in determining if any further action needs to be taken.
In addition, the U.S. Food and Drug Administration (FDA) has established guidelines on
assessing the safety, effectiveness, and quality of products containing nanomaterials, and the
FDA does not make categorical judgments on the safety or dangers of nanomaterials (epa.gov).
My discussion covers comparisons of old and recent articles, and I hope the data collected will
help expedite the EPA’s decision to take further action. The current investigation contributed to
the field of nanomaterial toxicity to gain a better understanding of how CdSe/ZnS-QDs and
AgNPs affect living organisms differently and on how nanomaterials of different compositions
and shell/core structures interact with cellular environments. To my knowledge, this is the first
RNA-seq report on an estimated 4.1 nm CdSe/ZnS-QDs in the budding yeast, Saccharomyces
cerevisiae, providing a list of differentially expressed genes. Furthermore, I offered a
comprehensive model of CdSe/ZnS-QD impacts on cell physiology, which was compared to the
previously proposed model that postulates AgNP-mediated changes occurring in yeast.
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The Role of the Carboxylic Acid Ligand. The CdSe/ZnS-QDs were synthesized with a
carboxylic acid stabilizing ligand that is capped on the surface on the ZnS shell. The undissociated form of a carboxylic acid is lipid-soluble and capable of crossing the membrane by
diffusion and can be taken up by specific transport proteins [120]. Once inside the cell, the pH
change causes carboxylic acids to dissociate into anions and accumulate because they can no
longer diffuse out of the cell. A build-up of protons can increase the acidity of the cytoplasm and
change the normal regulation of several metabolic pathways [120]. In addition, a build-up of
protons can also generate free radicals that cause oxidative stress. I did not find any increase in
ROS, but the accumulation of the QDs in the cell might be altering metabolic gene regulation by
decreasing the cellular pH. The budding yeast possesses active transport systems that allow
carboxylic acid-containing molecules, such as acetate, pyruvate, and lactate, to cross the plasma
membrane [120]. These alternate metabolic pathways are typically turned on in the absence of
glucose in a process called the diauxic shift [120]. During the diauxic shift, this study found 700
genes increased in their expression, and 1000 genes decreased in their expression [120].
Interestingly, when comparing yeast cells grown in glucose with cells grown in acetate, genes
involved in activating translation machinery, rRNA maturation, and mitochondrial biogenesis
were upregulated [120], similar to the results I found during gene expression analysis. These
findings could suggest that many of the upregulated genes found in the presence of the
CdSe/ZnS-QDs could result from the carboxylic acid stabilizing ligands capped on to the surface
of the QDs.
Why CdSe/ZnS is Less Toxic Than AgNPs. Of the two nanomaterials, CdSe/ZnS-QDs
and AgNPs, the latter was found to have a profound negative effect on cellular proliferation,
while no effect was observed in CdSe/ZnS-treated cells (Figure 9). Geisler-Lee et al. (2013)
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recently demonstrated that approximately more than 10% of AgNPs released Ag+ ions in 24 h of
exposure in plants [121]. Therefore, I conjectured that the growth defect observed in cells treated
with 20 nm AgNPs was due to, in part, potential leakage of Ag + ions out of the citrate coat.
However, the ZnS shell might efficiently prevent the short-term release of Cd2+ ions from
escaping the core of a Cd-based QD, which led to no growth defects. This assumption can be
supported by a previous study that found CdSe/ZnS-QDs, conjugated with COOH, are
significantly degraded in cells after two days of exposure. Furthermore, Cd 2+-mediated toxicity
only occurs when cellular Cd2+ concentrations exceed a certain threshold, and in highly
proliferating cells, in which cell division exceeds the rate of free Cd 2+ release [16]. Yeast is
known to have a 90-min doubling time, and it is likely that its rate of proliferation may exceed
the rate of Cd2+ release, which could explain the lack of physiological effects seen.
Nonetheless, there appears to be at least 240% more differentially expressed genes
(DEGs) in CdSe/ZnS-treated cells than in Ag-treated (Figure 14). This is possibly due to
CdSe/ZnS being internalized and trafficked to the nucleus, where it can interact with the
biomolecules in the vicinity [122], implicated in particularly with transcription rates. For
instance, Cd-QDs can interfere with transcription mechanisms (DNA/RNA polymerases) to alter
normal gene expression. To support this claim, a previous publication revealed low levels of
Cd2+ ions cause significant chromosomal damage in HFF-1 cells exposed to 7.5 nM QDs, while
no physiological damage was observed [98]. Amongst the upregulated genes found in
CdSe/ZnS- and AgNP-treated cells, I found many similarities in DEGs, such as an increase in
rRNA transcription, ribosomal assembly and protein synthesis, tRNA modifications, and nuclear
export. Some interesting differences found amongst the statistically upregulated genes between
the two nanomaterials is that CdSe/ZnS-treated cells have a drastically higher number of DEGs
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involved in amino acid metabolic processes. Amongst the downregulated genes found in each
treatment of nanomaterial, I found similarities, such as a decrease in cellular ATP production,
endocytosis, cell plasma membrane/wall integrity, and responses to oxidative stress [39]. I found
a few notable differences amongst the downregulated genes in each treatment, the first being
about 10 times more genes involved in responding to chemicals and many more genes that play a
role in ubiquitin-mediated late endosome/multivesicular body trafficking/lysosomal degradation
in CdSe/ZnS-treated cells.

Figure 14. Gene expression Venn-diagram to visualize the shared and separate differentially
expressed genes when exposed to CdSe/ZnS QDs and AgNPs. (A) All significant and
upregulated genes found in CdSe/ZnS- and Ag-treated cells. The leftmost circle represents the
number of genes exposed to CdSe/ZnS, the rightmost circle represents the genes exposed to
AgNPs only, and the shared area of the two circles represents the quantity of shared differentially
expressed genes in both treatments. (B) All significant and downregulated genes. The leftmost
circle represents the genes exposed to CdSe/ZnS, the rightmost circle represents the genes
exposed to AgNPs, and the middle area represents the same differentially expressed genes in
both treatments.
In both Ag- and CdSe/ZnS-treated cells, no statistical change in the detectable ROS
levels was detected. Ting Zhang et al. (2015) measured the levels of four oxidative stress
markers, including hydroxyl radicals, in fibroblasts treated with CdSe and CdTe (2.2 nm) QDs,
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lacking a ZnS shell, at 3.5, 7, and 14 µg/mL and found no difference in hydroxyl radical levels at
3.5 and 7 µg/mL, but indicated a statistical difference in ROS at 14 µg/mL [101]. Therefore, I
surmised that CdSe/ZnS-QDs at 10 µg/mL and AgNPs at 5 µg/mL is not a sufficiently high
enough concentration to statistically increase the generation of mitochondrial ROS or superoxide
levels. Another possible explanation for not detecting a statistical change in mitochondrial ROS
is because there are many possible types of ROS produced in the cell, and I selected to quantify
only the superoxide for this study. The lack of ROS generation may also be attributed to the
presence of the ZnS shell and slower internalization due to the larger diameter [19] of the tested
CdSe/ZnS-QDs (4.1 nm).
A previous transcriptomic study on Chlamydomonas reinhardtii demonstrated that 20 nm
AgNPs (1.5 × 105 mg/L) and 10 nm CdTe/CdS-QDs (2.0 × 104 mg/L) did not induce oxidative
stress. The former induced significant damage to the cells’ structural integrity, while green alga
cells exposed to CdTe/CdS-QDs did not increase the expression of transcripts that encode
proteasome subunits [104]. Consistently, I found several proteasome subunit genes
(RPN1/2/3/4/5/6/7/8/9/11/13/14 and RPT2/3/4/5/6) to be significantly downregulated in
CdSe/ZnS-treated cells. This similar cellular response suggests that CdTe/CdS and CdSe/ZnSQD exposure may induce similar transcriptional responses due to their similar composition.
Additionally, AgNP-treated cells increased transcript levels that encode for proteins of the cell
wall and flagella, suggesting AgNPs are more harmful to structures exposed to the external
environment, whereas CdTe/CdS-treated cells downregulated more transcripts overall and
resulted in less damage to external structures [104]. Similarly, the Zymolase experiments
revealed CdSe/ZnS-QD exposure was less damaging to the cell wall and downregulated more
transcripts in yeast than AgNP exposure.
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It has long been thought that engineered nanoparticles could affect the integrity of the
mechanism of DNA-damage repair pathways, which, in turn, can negatively impact the cellular
homeostasis. The differentially expressed gene list contains genes that function in the yeast base
excision repair (BER) pathways, including APN2, NTG1, NTG2, RAD2, RAD4, RAD5, RAD6,
RAD7, and RAD9 (data not shown). Ogg1 is also implicated in a BER pathway to excise 8-oxoG
from the DNA backbone [123], and I found this gene to be highly upregulated. Further, genes
implicated in a post-replication uracil excision repair, such as DUT1, UNG1, and REV1 [124],
were differentially expressed in the presence of CdSe/ZnS according to my list. Nucleotide
excision repair (NER) pathway has the capacity to remove a large number of structurally
unrelated helix-distorting lesions [123]. The following genes implicated in the yeast NER
pathway were differentially expressed: ABF1, RAD2, RAD3, RAD7, RAD16, and RAD26. Taken
together, my data provides evidence that CdSe/ZnS poses a threat to DNA repair pathways, and
therefore, the precise action mechanism behind the threat awaits to be explored.
Upregulated mRNA Transcripts Implicated in Promoting Translation. I provided a
model (Figure 15A,B) postulating potential physiological effects, induced by exposure to
CdSe/ZnS-QDs. My model, therefore, depicted key differentially expressed genes and their
corresponding cellular functions. Of these upregulated genes, the most noticeable groups of
upregulated genes were for translation, including but not limited to, rRNA transcription,
ribosome subunit assembly, ribosome exit, tRNA maturation, and translation machinery
assembly in the cytoplasm. Given rRNA synthesis is a prerequisite for translation, my RNA-seq
data was consistent in the genes, such as ECM16 [125] and RPA4 [126], required for rRNA
synthesis; these genes were highly upregulated (Figure 15A). It is well known that rRNA
molecules are associated with pre-ribosomal proteins in the nucleolus to form precursors of large
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and small ribosomes, pre-large 66S subunit (LSU), and pre-small 40S subunit (SSU),
respectively. My model only provided three genes (FAF1, DBP8, and NSA2) with at least 3-fold
increases in their RNA transcripts, among many upregulated genes implicated in pre-ribosome
assembly (Figure 15A). The Saccharomyces Genome Database presents the gene products
of FAF1 [127] and DBP8 [128, 129] that are associated with the assembly of SSU,
whereas Nsa2 functions for LSU assembly [129]. In addition, the RNA-seq revealed that RNA
transcripts coding for ribosomal proteins, including RPS26B, RPS3, and RPL1B, were increased
by 40–100% (Figure 15A). The rise of these transcripts appears to be necessary to supply the
demands for making functional ribosome precursors, such as SSU and LSU, which consist of
rRNA and its binding partners, ribosomal proteins. After transportation to the cytoplasm with the
aid of nucleoporins, such as Nup2 [130] and Pom152 [131], the SSU and LSU join together
along with tRNAs to make a translation-competent supramolecular complex that manufactures
proteins de novo to replace nonfunctional proteins that might have been damaged by exposure to
ROS [132, 133]. In addition to increasing the rate of ribosomal production, I also noticed genes
involved in tRNA maturation to be significantly increased to provide additional amino acid
products required in translation. Finally, genes that aid in the initiation process of translation,
including FUN12 [134], are upregulated.
Downregulated mRNAs and Their Potential Impacts on the Cell Integrity. Based on
the list of GO-terms generated with downregulated genes from the RNA-seq data, I illustrated
the physiological effects or cellular processes induced by exposure to CdSe/ZnS-QDs (Figure
15B). I found that the exposed cells expressed decreased levels of RNA transcripts involved in
oxidation-reduction processes, response to chemicals, pathways of endo/exocytosis, and various
metabolic processes (Figure 10). Similar to the model for upregulated genes (Figure 15A), my
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Figure 15. Schematic models of changes in cellular processes with CdSe/ZnS-QDs in yeast
cells. Genes are strategically placed near representative illustrations they are thought to be
involved in. (A) CdSe/ZnS leads to an increase in the expression of genes implicated in the preribosomal assembly of small and large subunits and their nuclear export as well as maturing
tRNA and complete ribosomes. (B) Several processes appear to be affected by exposure to
CdSe/ZnS, including cell wall/membrane integrity, sugar import (see the main text), late
endosome/multi-vesicular body function, and cellular respiration in the mitochondria.
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model for downregulated genes highlighted only a few downregulated genes in the model that
represent several more downregulated genes involved in the same cellular process. First, genes
involved in endocytosis, including but not limited to MYO3, were downregulated. This indicates
a potential defect in endocytosis with less number of copies of Myo3 at the endocytic site, and
therefore, it is of great interest in testing whether the endocytic process is hampered in the
presence of Cd-QDs. Furthermore, it has been shown that CdSe/ZnS-QDs use endocytosis as the
main route for their uptake, according to Liu et al. (2015) [19], but the question of whether they
affect the process and rate of endocytosis, directly or indirectly, remains unknown. I found
several downregulated genes that play a role in glycolysis. Among these genes, ENO1 and GUT1
code for a phosphopyruvate hydratase [135] and a glycerol kinase [136], respectively. Along
with these genes, seven HXT genes (HXT 2/17/5/4/9/8/13) and five SNF (SNF3/1/4/7/11) genes
coding for sugar transporter (SGD) were significantly downregulated based on the RNA-seq in
response to Cd-QD exposure. It is highly likely that sugar transport genes and sugar-breaking
enzyme genes mentioned above are simultaneously affected by the presence of Cd-QDs.
However, I cannot exclude the possibility that ENO1 and GUT1 genes are downregulated as a
consequence of low levels of sugars transported caused by the suboptimal activity of glucose
transporters due to the presence of Cd-QDs.
Other mitochondrial genes (ATP20, COX7, COX12, COX20, RCF1, and QCR6) involved
in respiration aid in ATP synthesis [137], electron transport complexes [138], and cytochrome c
oxidase subunits [139, 140] were downregulated, suggesting energy production was significantly
lessened. These genes code for transmembrane proteins residing at the inner membrane of
mitochondria (Figure 15B), and their gene products play a major role in relaying electrons via
reduction-oxidation cycles. Additionally, these proteins are aiding in transporting H+ ions from
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the matrix to the inner membrane space to create a proton gradient across the inner membrane.
The energetic proton flow down the gradient facilitates ATP formation via the help of ATP20, a
part of the ATP-synthase protein complex. Other metabolic genes, CCP1 and ALD6, are required
in the citric acid cycle (TCA cycle) and NAD+ regeneration, respectively [141]. Their highlydownregulated expression is suggestive of diminished levels of the electron carriers NADH,
available for the electron transport chain (ETC), which may lead to the production of suboptimal
amounts of ATP. Interestingly, mitochondrial genes involved in neutralizing ROS, such
as CCP [141], are downregulated as well, thereby possibly contributing to increased ROS levels
that result in cellular damage tied together. Downregulation of genes coding for mitochondrial
ETC transmembrane proteins, TCA cycle proteins, and ROS neutralizing proteins might
additively or synergistically aggravate mitochondrial functions, which is not a favorable
environment to support many cellular processes that require ATP for their action mechanism.
However, as depicted in the upregulation model (Figure 15A), I proposed an abnormally
elevated translation process upon Cd-QD exposure. This does not seem to be consistent with the
diminished level of ATP in cells with Cd-QDs. One possible explanation for this would be that
the majority of available energy produced may be directed towards increasing translation. I
conjectured that proteins in diverse cellular processes are damaged with the presence of Cd-QDs,
making the cell prioritize the replenishment of the damaged proteins.
Late endosome/multivesicular body (MVB) genes (VPS4/36/55, MVB12, COS1/5/8/10,
and SHH4) involved in ubiquitin (Ub)-dependent sorting of receptor proteins for vacuole
degradation are significantly downregulated. Ub is a sorting tag that mediates the entry of wornout receptors into intraluminal vesicles (ILVs) that is targeted to the lysosome or vacuole for
degradation [142]. It is well understood how endosomes/MVBs play a role in the balance
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between recycling and degrading proteins and lipids. This robust balancing act, consequently,
contributes to diverse cellular processes, such as nutrient uptake, cell adhesion, cell migration,
cytokinesis, cell polarity, and signal transduction [143]. In addition, UBI4, a gene that codes for
ubiquitin [144], is also found to be downregulated by approximately 100%, according to my
data. This suggests that receptor proteins destined for degradation in Cd-QDs exposed cells are
not being turned over as efficiently as in healthy cells. With available energy in the cell more
limited from mitochondrial damage, the cell likely compensates by downregulating regular
processes, such as endosomal sorting and transport pathways. Modifying normal cell functions
like the ones mentioned might allow the cells to conserve energy for processes of a higher
priority, namely translation, for replacing proteins damaged by CdSe/ZnS-QD exposure. From
my DEG analysis, I postulated that worn out and damaged receptor proteins accumulate due to
late endosomal and proteasome downregulation. In addition, a previous study on the 20S
proteasome subunit in maize revealed that the proteasome plays an important role in providing
metal resistance in Saccharomyces cerevisiae [145]. These results suggest that the cell is
choosing to redirect energy meant for degradation to higher priority processes, while
simultaneously compromising its metal resistance. I observed no physiological effects, which
suggests this possible energy prioritizing was not great enough to cause significant damage but
was still detectable with high throughput sequencing technology.

Conclusion
The present work provided evidence that CdSe/ZnS-QDs exerted a mild cytotoxic effect
on yeast when compared with AgNPs, but it was evident that Cd-QD-treated cells had more
differentially expressed genes than AgNPs-treated cells. My working model behind the steep
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upregulation in ribosomal biogenesis was most likely due to possible carboxylic acid stabilizing
ligands interacting with cellular components or Cd-QD interactions with the damaged proteins as
the stable QD particle or as free Cd2+ ions released from Cd-QDs. Whereas, a wide spectrum of
routine cellular processes, including energy production and intracellular trafficking, appeared to
be significantly impeded. We, therefore, proposed that the majority of available energy in the
cell is directed to aid translation in order to replenish damaged proteins from Cd-QD exposure.
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CHAPTER 4: COMPARING TRANSCRIPTOME PROFILES OF SACCHAROMYCES
CEREVISIAE CELLS EXPOSED TO CADMIUM SELENIDE/ZINC SULFIDE AND
INDIUM PHOSPHIDE/ZINC SULFIDE

Introduction
Quantum dots (QDs) are nano-sized semiconductor crystals well-known for their longlasting fluorescence, photo-stability, and tunable optic properties [146-148]. The color of each
QDs fluorescence is size-dependent, therefore, changing a QDs size will directly change its
emission wavelength [148]. Soon after their development and introduction to the biological
sciences, QDs proved to be powerful fluorescent probes [149, 150] that work better in
applications that include nucleic acid detection, protein tracking, intracellular reporting,
molecular imaging, drug delivery, and tumor diagnostics [147, 148, 151, 152]. Biological
imaging with QDs is possible through modifying their surface by conjugating them with targetspecific antibodies, peptides, or small molecules [147]. Despite their advantages, the use of QDs
raises a lot of concern regarding their potential negative effects [146]. QD cytotoxicity has been
investigated in many cell models including, but not limited to, yeast [22, 47], bronchial epithelial
cells [153], macrophages, lymphocytes [107], and animal models such as mice [154], rats [155,
156], and non-human primates [156]. Some negative effects are, in part, due to their nano-size
which enables them to adversely interact with organismal and microbial environments, including
lung alveoli [157] and DNA within the nucleus of a cell [101, 146]. To combat these potential
hazards, protective semiconductor shells have been developed that coat the toxic core of QDs.
Zinc sulfide (ZnS) is a protective shell, encapsulating QDs, that can be synthesized onto the core
of QDs (such as CdSe and InP, respectively) and have been shown to reduce cytotoxic effects
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[146, 158]. Despite these attempts to improve their safety, concerns regarding exposure to QDs
and QD-containing products persist [146, 159].
Several previous studies have revealed Cd- and Pb-based QDs to be toxic, causing
significant cellular damage [146, 160], but cadmium selenide, cadmium telluride, and cadmium
sulfide (CdSe, CdTe, and CdS, respectively) QDs are the most widely used [118]. Cadmium is a
well-known carcinogen, that has been shown to damage the liver and kidneys, and the use of CdQDs in electronics has been banned by the European Union [161]. According to previous studies
on Cd-QDs, heavy metal ions released from the surface of degrading QDs induce toxicity by
indirectly inducing the generation of reactive oxygen species (ROS) [19, 160]. Due to these
findings, there is still much debate over the risks of Cd-QD exposure and the continuation of
their use in products and clinical research [162].
To overcome obstacles surrounding QD toxicity, a less toxic, Cd-free, QD could be a
potential solution. A previous study provided evidence that InP/ZnS QDs are a less hazardous
semiconductor nanocrystal compared to Cd-containing QDs [163, 164]. InP/ZnS QDs, similar to
CdTe-QDs, can fluoresce, which has made them a practical alternative to Cd-QDs [118]. Studies
conducted in vivo found an accumulation of indium from InP/ZnS QDs remained in major
organs up to 84 days after injection in BALB/c mice, but histological analysis of the organism’s
blood did not reveal any discerning toxic effects [164]. A recent study revealed that InP/ZnS
QDs are taken up into cells and high doses decreased cell viability and induced ROS generation
and apoptosis [160].
Challenges regarding InP QDs, including their rapid oxidation and break down in
biocompatible solutions, must be solved to reduce their cytotoxicity [118]. Similar to CdSe, InP
QDs are coated with a ZnS-shell that improves stability and reduces toxicity [118]. Previous
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studies have identified a potential drawback, by demonstrating the poor coordination strength
between InP-cores and ZnS-shells, which makes it difficult for the core to be fully coated,
resulting in holes that expose the InP-core. The addition of a second ZnS-shell to InP/ZnS QDs
has been shown to improve coverage around InP-cores and reduce cytotoxicity [118].
Additionally, they revealed InP/ZnS QDs increased ROS levels, primarily superoxide, and
InP/ZnS QDs with a second ZnS-shell reduced ROS levels, in the budding yeast [118].
Although InP-QDs has been suggested as a potential replacement for Cd-QDs due to their
similar analogous bandgap characteristics to Cd-QDs [118], I attempted to better understand the
potential mechanisms of toxicity of CdSe/ZnS and InP/ZnS QDs on the budding yeast,
Saccharomyces cerevisiae. The present study implemented high throughput technologies (RNAseq) to assess alterations in the transcriptomic profile of QD-treated yeast and examined the
cytotoxic effects in response to CdSe/ZnS and InP/ZnS exposure. This study aims to measure
toxicity by assessing each QDs effect on proliferation, ROS levels, and change in gene
expression. Further, I investigated QD-mediated effects on cellular trafficking and found that
CdSe/ZnS and InP/ZnS significantly alter Vps10-GFP trafficking. A detailed discussion on the
potential toxic effects and their impacts on the cell caused by these quantum dots is provided in
the discussion section.

Results
CdSe/ZnS QDs and InP/ZnS QDs Affect Normal Yeast Growth. To fully examine the
effects of CdSe/ZnS QDs on yeast growth, I recorded the optical density of each sample (0, 10,
20, 50, and 100 μg/mL CdSe/ZnS) for 24 h (Figure 16). CdSe/ZnS QDs did not have a
significant effect on yeast growth curves compared to the non-treated control, but higher
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concentrations of CdSe/ZnS (20, 50, and 100 µg/mL) seemed to slightly stimulate growth as
seen by the top 3 growth curves (red, orange, and green curves) in Figure 16A. InP/ZnS QDs
significantly reduce yeast growth in a dose-dependent fashion (Figure 16B). Next, I graphed the
final ODs of each sample at a steady-state on hour 24 (OD594 nm). I found CdSe/ZnS QDs had no
significant effect on endpoints (Figure 16C) compared to the non-treated control. Once again, I
show InP/ZnS QDs had a dose-dependent effect on growth. As concentrations increased,
endpoints steadily decreased, and the highest concentration (100 µg/mL) was significantly
reduced (Figure 16D). Furthermore, I calculated the doubling times of the yeast in each sample
with the slope of the growth curve in the exponential phase (Figure 16E,F) and recorded the
amount of time each sample remained in lag-phase (Figure 16G,H). Yeast treated with CdSe/ZnS
QDs displayed no significant change in their endpoint OD (Figure 16C) or doubling times apart
from yeast treated with 50 μg/mL CdSe/ZnS, which showed a significant increase in doubling
time (Figure 16E). However, the amount of time spent in the lag-phase was significantly
decreased in samples treated with 10, 50, and 100 μg/mL CdSe/ZnS (Figure 16G). The same
components used to analyze the growth of yeast were investigated in samples treated with
InP/ZnS QDs at concentrations of 0, 1, 10, 50, and 100 μg/mL. Interestingly, InP/ZnS QDs
seemed to significantly decrease the endpoint OD at 100 μg/mL (Figure 16D) as well as
significantly increase the doubling times of samples at concentrations of 1, 50, and 100 μg/mL
(Figure 16F). Unlike CdSe/ZnS treated samples, yeast exposed to InP/ZnS QDs caused no
significant difference in time spent in lag-phase when compared to the non-treated control
(Figure 16H). Taking all the growth data obtained from CdSe/ZnS and InP/ZnS exposed yeast, a
side-by-side comparison reveals each QD affects growth differently. CdSe/ZnS-treated samples
significantly altered time spent in a lag phase when compared to the non-treated control and had
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little to no effect on the endpoint ODs or doubling times. In contrast, InP/ZnS-treated samples
significantly changed the endpoint ODs and doubling times and had no significant effect on time
spent in lag-phase.
Due to recent advances in high-throughput sequencing technologies, we can now identify
a very broad range of genes and cellular processes that change when exposed to certain
materials. All CdSe/ZnS- and InP/ZnS-treated and non-treated samples underwent a total RNA
extraction followed swiftly by an mRNA purification and cDNA conversion step. Each group,
performed in triplicate, was sent to the Kansas Medical Genome Center where they sequenced
the cDNA in each sample with an Illumina HiSeq 2500 sequencing system (Illumina ®, San
Diego, CA, USA) that created datasets of sequenced data of each sample replicate. All cDNA
datasets were returned online and then uploaded to usegalaxy.org for computational data
analysis. All three control and QD-treated replicates were concatenated resulting in one joined
file of the three non-treated samples, one file of the three CdSe/ZnS-treated samples, and one file
of the three InP/ZnS-treated samples. Next, each cDNA dataset was checked for quality (FastQC
and FASTQ Quality Trimmer, respectively). After each dataset was cleaned up, they were
mapped to the S. cerevisiae reference genome (S288C). A combined total of 81,205,179 reads
were accepted from the three non-treated controls, a total of 79,562,512 and 82,520,772 accepted
reads were accepted from the three Green CdSe/ZnS-treated samples and the three InP/ZnStreated samples, respectively.
For CdSe/ZnS QD treated samples, 606 upregulated genes were identified and found to
be implicated in transmembrane transport (13.6%), carboxylic acid metabolic processes (11.4%),
amino acid metabolic processes (7.1%), cellular homeostasis (6.1%), cellular glucan metabolic
processes (2.3%), and drug transmembrane export (0.8%), as depicted in Figure 17A. From the
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Figure 16. Growth assay to determine growth rates of CdSe/ZnS and InP/ZnS-treated yeast cells.
(A,B) Quantification of cell optical densities over a 24-h period where the cells are treated with
CdSe/ZnS and InP/ZnS QDs, respectively, at 30 °C while shaking. (C,D) Measurement of cell
optical densities at 24 h of treatment with CdSe/ZnS and InP/ZnS QDs, respectively. The bar
representing the average optical densities (ODs) (594 nm) of each concentration at the 24-h
mark. (E,F) Doubling time takes place during the phase of exponential growth for the cells
treated with CdSe/ZnS and InP/ZnS QDs, respectively, and was measured as the amount of time
it takes for cells to double their ODs. (G,H) The mean lag time before the exponential growth
phase. Significant statistical differences are represented with *(p < 0.05), **(p < 0.01), and ***(p
< 0.001).
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GO terms listed above, 83, 69, and 37 upregulated genes were involved in transmembrane
transport, carboxylic acid metabolism, and amino acid metabolism, respectively. Furthermore,
43, 14, and 5 upregulated genes were implicated in cellular homeostasis, cellular glucan
metabolism, and drug transmembrane export, respectively (Figure 17A). From the pool of 2760
downregulated genes, many were involved in the macromolecule metabolic process (42.3%),
component organization/biogenesis (36.9%), nitrogen compound metabolism (33.0%), protein
metabolic processes (21.7%), and translation (8.6%). Among the downregulated GO terms listed
above, 694, 612, 325, and 175 downregulated genes were found to be involved in metabolic
processes, nitrogen compound metabolic processes, protein metabolic processes, and translation,
respectively. Moreover, 152, 141, 103, 61, and 59 downregulated genes play a role in ncRNA
processing, rRNA metabolic processes, ribosomal biogenesis, cell wall
organization/biosynthesis, and external encapsulation structure organization, respectively. Lastly,
28, 22, and 17 downregulated genes were found to be implicated in large and small ribosomal
assembly and rRNA export from the nucleus, respectively (Figure 17B).
In InP/ZnS-treated samples, 6488 genes were mapped to the genome and annotated, and
of those genes, 2620 were found to be statistically increased or decreased compared to the nontreated controls. 1523 genes were found to be upregulated and 1097 genes downregulated. For
Inp/ZnS QD treated samples, through analysis of GO terms, I identified several upregulated
cellular processes including oxidation-reduction (11.8%), transmembrane transport (9.9%), drug
metabolic process (6.1%), metal ion homeostasis (3.3%), electron transport chain (2.2%),
cellular respiration (1.7%), glycogen metabolic process (1.2%), and NADP metabolic process
(1.1%) (Figure 18A). From the GO-term analysis, I determined 180, 150, 93, and 51 upregulated
genes are involved in oxidation-reduction, transmembrane transport, drug metabolic processes,
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and metal ion homeostasis, respectively. Additionally, 34, 30, 18, and 16 upregulated genes were
found to be involved in the electron transport chain, cellular respiration, glycogen metabolic
processes, and NADP metabolic processes, respectively (Figure 18A). From all 1097
significantly downregulated genes, several were found to be involved in nitrogen compound
metabolic processes (55.8%), cellular component organization/biogenesis (41.1%), protein
metabolic processes (29.6%), translation (16.0%), ncRNA processing (13.9%), rRNA processing
(11.9%), ribosome biogenesis (9.4%), cell wall organization/biogenesis (5.6%), external
encapsulating structure organization (5.4%), ribosomal small and large subunit assembly (2%
and 3.1%, respectively), and rRNA export from the nucleus (1.6%). GO analysis revealed that
612, 451, 325, and 175 downregulated genes play important roles in nitrogen compound
metabolic processes, cellular component organization/biogenesis, protein metabolic processes,
and translation, respectively. In addition, 152, 130, 103, 61, and 59 downregulated genes are
involved in ncRNA processing, rRNA processing, ribosome biogenesis, cell wall
organization/biogenesis, and external encapsulating structure organization, respectively. Lastly,
28, 22, and 17 downregulated genes were identified to play a role in the GO terms ribosomal
small subunit assembly, ribosomal large subunit assembly, and rRNA export from the nucleus,
respectively (Figure 18B).
RT-qPCR Validation of RNA-Seq Data. I then wanted to validate the fidelity of the
RNA-seq results using RT-qPCR. With the Pfaffl method, I determined the fold-change of the
downregulated genes (SPS100, YDL012C), upregulated genes (TIR1, HXK1), and housekeeping
gene (ALG9) using RT-qPCR (Figure 19). The fold-change of CdSe/ZnS-treated SPS100 had an
average fold-change of 0.72 and InP/ZnS-treated YDL012C had an average fold-change of 0.34
(Figure 19A&B). CdSe/ZnS-treated cells displayed an elevation of TIR1 mRNA level which had
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Figure 17. Bar graphs depicting the number of DEGs implicated in GO-terms from CdSe/ZnS
and InP/ZnS-treated samples. The number of differentially expressed genes (DEGs) on each bar
represents the number of an altered gene for the corresponding GO-term with p-values of 0.05 or
below. The key with the corresponding GO-term. (A) The total number of upregulated DEGs
implicated in the listed GO-terms in CdSe/ZnS-treated cells. (B) The total number of
downregulated DEGs implicated in the listed GO-terms in CdSe/ZnS-treated cells.
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Figure 18. Bar graphs depicting the number of DEGs implicated in GO-terms from InP/ZnStreated samples. The number of differentially expressed genes (DEGs) on each bar represents the
number of an altered gene for the corresponding GO-term with p-values of 0.05 or below. The
key with the corresponding GO-term. (A) The total number of upregulated DEGs implicated in
the listed GO-terms in InP/ZnS-treated cells. (B) The total number of downregulated DEGs
implicated in the listed GO-terms in InP/ZnS-treated cells.
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an average fold-change of 1.29, and the HXK1 mRNA level in InP/ZnS-treated cells was
increased more than 10 times when compared to that in non-treated cells (Figure 19A&B). Gene
expression values below 1.0 are interpreted as downregulated and expression values greater than
1.0 are interpreted as upregulated genes compared to non-treated samples. Together, the RTqPCR results clearly validated the RNA-seq results.
ROS Quantification in Response to CdSe/ZnS and InP/ZnS Exposure. It has long
been believed that the cytotoxicity of QDs is, in part, due to their ability to cause oxidative stress
in cells. Most studies will measure the levels of ROS to determine how much oxidative stress
QDs are inflicting in certain cells and organisms. In my study, CdSe/ZnS and InP/ZnS QDs
affected yeast differently according to the growth curves and gene expression data. I decided to
measure ROS levels in CdSe/ZnS and InP/ZnS treated samples to determine if one is causing
more oxidative stress than the other. Additionally, Table 4 depicts multiple genes implicated in
antioxidant defenses [165] and shows the effect of Cd and InP QDs on each gene’s expression to
provide more insight on how they change oxidative stress response mechanisms in yeast. I
quantified ROS levels (superoxide and peroxynitrite) in samples treated with CdSe/ZnS and
InP/ZnS QDs at 10 and 100 µg/mL, respectively (Figure 20). The cells were cultured for six
hours with the nanomaterials, then allowed to grow for 2 h with DHE (dihydroethidium) and
DHR-123 (dihydrorhodamine-123) prior to measuring the oxidized DHE and DHR fluorescent
byproducts, which indicate levels of superoxide and peroxynitrite, respectively (Figure 20). No
significant changes in ROS levels were observed in yeast treated with 10 µg/mL CdSe/ZnS or
InP/ZnS (Figure 20E,J). In cells dyed with DHE and treated with 100 µg/mL CdSe/ZnS, I
observed a significant increase in superoxide levels (Figure 20C,E). In cells dyed with DHE and
treated with 100 µg/mL InP/ZnS, I observed a significant decrease in superoxide levels (Figure
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20D,E). In cells treated with DHR123, I observed a significant increase in peroxynitrite levels in
those exposed to 100 µg/mL CdSe/ZnS QDs (Figure 20H,J) and a significant decrease in cells
exposed to 100 µg/mL InP/ZnS QDs (Figure 20I,J). This suggests that both QDs have a unique
effect on the generation of ROS in yeast and do not significantly affect ROS levels at
concentrations lower than 10 µg/mL.

Figure 19. Gene expression ratios of ALG9 and one up- and downregulated gene from QDtreated samples determined by RT-qPCR. The reference gene ALG9 and other differentially
expressed genes (from CdSe/ZnS and InP/ZnS-treated samples) were selected from the RNA-seq
expression data and validated by determining their relative fold-change using the Pfaffl method.
(A) Upregulated (TIR1) and downregulated (SPS100) genes with significantly altered gene
expression levels Compared to ALG9 when treated with CdSe/ZnS. (B) Upregulated (HXK1)
and downregulated (YDL012C) genes with significantly altered gene expression levels compared
to ALG9 when treated with CdSe/ZnS. One asterisk (*) represents p<0.05, while 4 asterisks
(****) represent p<0.0001.
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DEGs Implicated in Cellular Trafficking. To better understand the mechanisms behind
CdSe/ZnS and InP/ZnS toxicity, I investigated their effects on intracellular trafficking. Vps10GFP was used to identify alterations in the intracellular trafficking of cargo between the

Table 4. DEGs Implicated in Antioxidant Defense
Yeast Antioxidant
Genes

Function

Cd UpReg.

Cd
DownReg.

InP UpReg.

InP
DownReg.

x

SOD1

x

x

x

x

SOD2

x

x

x

CTT1

x

x

GPX1,

GPX1

GPX2

TRX2

x

x

OGG1

x

x

Primary Antioxidant Defenses
SOD1 (cytoplasmic
superoxide
dismutase)
SOD2
(mitochondrial
superoxide
dismutase)
CTT1 (cytoplasmic
catalase T)
GPX1–GPX3
(glutathione
peroxidases)
TRX2 (cytoplasmic
thioredoxin)

Dis-mutation of
superoxide radicals

Decomposition of
hydrogen peroxide
Reduction of hydrogen
peroxide, Reduction of
alkyl hydro-peroxides
Reduction of hydrogen
peroxide and alkyl
hydro-peroxides

GPX2
x

Table 4 Continued. DEGs Implicated in Antioxidant Defense
Secondary Antioxidant Defenses
OGG1 (8oxoguanine
glycosylase/lyases)

Excision of oxidized
DNA bases

x
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APN1 (AP
endonuclease)

Cleavage of
apurinic/apyrimidinic
(AP) sites, Generation
of 3′-hydroxyl groups
at AP sites

x

APN1

APN1

x

Reduction of protein
disulfides
GRX2 (glutaredoxin) Reduction of disulfides
Reduction of protein

GSH1

X

x

x

x

x

GRX2

x

TRX2 (thioredoxin)

TRX2

x

x

x

GLR1

x

GLR1

x

x

x

TRR2

x

x

x

ZWF1

x

x

ZWF1

x

GSH1 (glutathione)

disulfides, Reduction of
oxidized glutathione
GLR1 (glutathione
Reduction of oxidized
reductase)
glutathione
TRR2 (mitochondrial Reduction of oxidized
thioredoxin reductase)
thioredoxin
ZWF (glucose-6- Reduction of NADP+ to
phosphate
NADPH
dehydrogenase)

Table 4 Continued. DEGs Implicated in Antioxidant Defense
ZWF (glucose-6phosphate
dehydrogenase)

Reduction of NADP+ to
NADPH

x

Tagging oxidized
UBI4 (polyubiquitin) proteins for degradation
UBI4
x
UBI4
x
by the 26S proteasome
A table of genes implicated in antioxidant defense. It represents upregulated and downregulated
genes in yeast exposed to CdSe/ZnS and InP/ZnS QDs. All genes incorporated in this table had
p-values of 0.05 or below.
endosomes and Golgi. I hypothesized that CdSe/ZnS and InP/ZnS QDs would increase the
number of Vps10-GFP puncta in yeast cells, more so in InP/ZnS QDs due to their more severe
effects on growth. A previous study using cultured human cells revealed COOH-CdSe/ZnS QDs
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were continuously taken up and accumulated in the endosomes. Additionally, they noted that the
QDs were internalized at a fast rate and remained persistent up to six hours, which could
possibly account for the greater number and disorder of Vps10-GFP puncta in the CdSe/ZnStreated cells, but there are very few publications on the effects of QDs on intracellular
trafficking.
In Table 5, I provided specific and in-depth information, such as the genes incorporated
in intracellular trafficking complexes and whether those genes were upregulated or
downregulated in samples exposed to CdSe/ZnS or InP/ZnS QDs. Due to the number of DEGs
that were found to be involved in cellular trafficking complexes (Table 5), I decided to use
confocal microscopy and yeast with GFP-tagged Vps10 (Vps10-GFP) to observe defects in
trafficking. Defects in Vps10-GFP trafficking toward the trans-Golgi network were quantitated
by comparing the number of Vps10-GFP puncta in QD-treated cells with untreated samples.
Figure 21 revealed CdSe/ZnS QDs significantly increased the number of Vps10-GFP puncta
after 6 h of incubation. In contrast, InP/ZnS QDs significantly decreased the number of Vps10GFP puncta, resulting in fewer larger Vps10-GFP puncta compared to CdSe/ZnS.
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Figure 20. The Quantification of ROS levels in yeast treated with CdSe/ZnS and InP/ZnS QDs.
Samples were treated with and incubated with dihydroethidium (DHE) or dihydrorhodamine
(DHR) 2 h prior to measuring the oxidized DHE and DHR fluorescent byproducts, which was
measured with flow cytometry, that allow us to observe changes in superoxide and peroxynitrite
levels generated in each QD-treatment, respectively. (A) Non-treated sample without DHE. (B)
Non-treated sample dyed with DHE. (C) DHE dyed sample treated with 100 µg/mL CdSe/ZnS.
(D) DHE dyed sample treated with 100 µg/mL InP/ZnS. (E) Bar graph comparing % changes in
superoxide levels. (F) Non-treated sample without DHR. (G) Non-treated sample dyed with
DHR. (H) DHR dyed sample treated with 100 µg/mL CdSe/ZnS. (I) DHR dyed sample treated
with 100 µg/mL InP/ZnS. (J) Bar graphs comparing % changes in peroxynitrite levels. One
asterisk represent p<0.05 and four asterisk represent p<0.0001.
Table 5. Upregulated DEGs Implicated in Cellular Trafficking
Complex
CdSe/ZnS-Treated
InP/ZnS-Treated
Upregulated Genes
SNARE

x

Retromer

x

NYV1, TLG2, SPO20, YPT7
x
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Sorting Nexin

SNX41

SNX4, SNX41

GARP

x

VPS52, VPS54

Downregulated genes

Retromer

PEP12, VTI1, NYV1, YKT6, VAM3, PEP12, VAM7, SSO1, SNC2, SED5
VAM7, TLG1, TLG2, SSO1, SSO2,
SEC9, SNC1, SNC2, SED5, GOS1,
UFE1, USE1, SEC22, BOS1, BET1,
VPS21
VPS5, VPS17. VPS29, VPS35
VPS29

Sorting Nexin

SNX3, SNX4, MVP1

x

GARP

VPS51, VPS52, VPS53

VPS51

SNARE

A table that compares upregulated DEGs involved in cellular trafficking processes when exposed
to green CdSe/ZnS and InP/ZnS QDs. The processes of interest include SNARE components, the
Retromer, Sorting Nexin, and GARP complexes. All genes incorporated in this table had Pvalues of 0.05 or below.
Discussion
It has been well established that Cd-based QDs exhibit high levels of toxicity and their
implementation in commercial and biomedical products has been an issue of concern. Recently,
it has been suggested that Cd-based QDs could be replaced by less toxic InP-based QDs. Despite
a large amount of research on Cd-QD toxicity, there have been few articles on the toxicity of
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Figure 21. Cell images and bar graphs representing the number of Vps10-GFP puncta in
CdSe/ZnS- and InP/ZnS-treated samples. (A–D) Representative images of wild type Vps10-GFP
puncta in yeast. (E) Bar graph representing the average number of Vps10-GFP puncta per cell in
CdSe/ZnS-treated samples. (F) Bar graph representing the average number of Vps10-GFP puncta
per cell in InP/ZnS-treated samples. (A, C) Representative immunofluorescence image of a wild
type Vps10-GFP cell from an NTC sample. (B) Representative immunofluorescence image of a
cell from a sample treated with 10 µg/mL CdSe/ZnS. (D) Representative immunofluorescence
image of a cell from a sample treated with 10 µg/mL InP/ZnS. Two asterisks represent p < 0.01
and four asterisks represent p < 0.0001.
InP-QDs and many researchers seemed to primarily focus on the effects QDs on growth and
ROS levels. A comparison study on the toxicology of Cd- and InP-based QDs is important in
determining if InP-QDs can safely replace Cd-QDs in future biological applications [163].
Regardless of which QD is more toxic, we cannot rule out the possibility that both QDs are
significantly toxic, which could be possible through differences in their mechanisms of toxicity.
My study investigated the cytotoxicity of CdSe/ZnS and InP/ZnS QDs on S. cerevisiae, and
similar to previous studies, I conducted growth and ROS assays as well. Additionally, I
conducted an in-depth genetic experiment (RNA-seq) to provide more specific information on
cellular processes affected by analyzing changes in the quantity of mRNA transcripts in QDtreated cells. To my knowledge, the present work is the first to compare CdSe/ZnS and InP/ZnS
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gene expression profiles and provide representative models of their cytotoxic effects.
Interestingly, I identified many DEGs implicated in endocytosis and sorting pathways.
Therefore, I attempted to visualize the effects of the QDs on intracellular trafficking by treating
wild-type yeast expressing Vps10-GFP with the QDs and observing any changes with confocal
microscopy. Together, I observed novel differences in the effects the QDs had on growth, ROS
levels, and trafficking in trans-Golgi and transmembrane vesicle sorting pathways.
InP/ZnS QDs Inhibits Proliferation. Proliferation assays demonstrated a clear
difference in effects between both QD-treatments, but InP/ZnS QDs appeared to have the
greatest negative effect on growth. I showed that InP/ZnS QDs had the greatest effect on cellular
growth at 100 µg/mL (Figure 16B), while CdSe/ZnS-treated cells displayed no significant
difference in growth at the same concentration (Figure 16A). These results are not consistent
with a study that tested the effects of double-capped CdSe/ZnS and InP/ZnS QDs, capped with
mercaptopropionic acid, on proliferation. Using a colorimetric WST-8 proliferation assay, they
showed CdSe/ZnS QDs significantly reduced viability in A549 (human lung carcinoma) and SH
SY5Y (human neuroblastoma) cells at concentrations as low as 10 pM, and InP/ZnS QDs had no
significant effect on viability at the same concentrations [163]. We cannot be sure if these
inconsistent findings could be due to a difference in surface ligands, such as the difference
between carboxylated shells and shells with mercaptopropionic acid ligands.
The MAPK pathway induces several cellular responses including proliferation,
differentiation, development, inflammatory responses, and apoptosis in eukaryotic cells [166].
MSG5, a gene downregulated in InP/ZnS-treated samples, encodes a nuclear and cytoplasmic
protein that inhibits the MAPK pathway through regulating MAPK nuclear export. One possible
explanation for the reduction in proliferation with InP QDs (Figure 16B) could be due to an
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MSG5-mediated immune response, triggering apoptosis. Apoptosis occurs normally in
eukaryotic cells, for instance, in development, aging, and maintaining homeostasis in cell
populations and is an important immune defense mechanism that occurs when cells become
damaged by disease and noxious agents [167]. It is important to note that many
conditions/stimuli can trigger apoptosis, and activation of apoptosis can differ between cell-types
[167]. I first suspected that the greater impact on proliferation, in InP/ZnS-treated cells, was
caused by a QD-mediated elevation in ROS, but after measuring ROS levels in QD-treated cells,
my results suggested otherwise. A recent study that investigated the toxicity of the exact same
InP/ZnS QDs on HeLa cells, found QD-treatments, at both 69 and 167 µg/mL, induced late
apoptosis 4417% more than the non-treated controls [7]. This suggests that the observed
reduction in proliferation by InP QDs might be primarily due to the activation of apoptosis
pathways instead of increased ROS levels in InP/ZnS-treated cells.
CdSe/ZnS and InP/ZnS QDs Have Opposite Effects on ROS Generation. I found
CdSe/ZnS QD treatments (100 µg/mL) significantly increased the levels of ROS, including
superoxide and peroxynitrite, and InP/ZnS (100 µg/mL) statistically significantly decreased both
ROS. Interestingly, a recent study that measured ROS levels in InP/ZnS-treated (69 and 167
µg/mL InP/ZnS) HeLa cervical cancer cells found InP/ZnS exposure to significantly decrease
superoxide levels and significantly increase peroxynitrite levels. The decrease in superoxide
levels they reported is consistent with my findings, but the increased peroxynitrite levels in their
experiments contradict the effects of InP/ZnS on peroxynitrite levels in yeast. Interestingly, in a
2019 study, I investigated the effects of yellow CdSe/ZnS QDs on superoxide levels in yeast and
found no significant change in ROS levels, but cells were treated with a much lower
concentration (20 µg/mL) than in the current study (up to 100 µg/mL) [22]. Additionally, a study
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on the cytotoxicity of InP/ZnS QDs used spin-trap electron paramagnetic resonance spectroscopy
and reporter assays that revealed InP/ZnS considerably increased superoxide and hydroxyl
radical levels in many cell types (NIH3T3 fibroblasts, KB cells, B16 murine melanoma cells, and
MDA-MB-231 breast adenocarcinoma cells) [118]. These types of discretions in ROS
production are not uncommon amongst different cell-types, including closely related, eukaryotic,
microorganisms [7].
The RNA-seq analysis identified many mitochondrial genes, involved in ATPase activity,
ETC, protein degradation, and mitochondrial translation, which were significantly
downregulated in the presence of CdSe/ZnS QDs (Figure 22B). I conjecture that the significant
decrease in metabolic activity, seen in CdSe/ZnS-treated samples, is directly associated with an
increase in ROS levels. I observed considerably fewer downregulated mitochondrial genes in
InP/ZnS-treated samples (Figure 22D) compared to CdSe/ZnS-treated samples (Figure 22B). On
the other hand, the gene data revealed my InP/ZnS-treated cells significantly increased the
expression of genes implicated in antioxidant defense activity, such as SOD2, CTT1, GPX1,
COQ3, APN1, GRX2, GLR1, TRR2, ZWF1, and UBI4 (Table 4). Additionally, I found an
increase in the transcription of genes implicated in peroxisome structure and activity (PEX3,
PEX5, PEX7, PEX15, PEX17, PEX18, PEX19, PEX27, PEX29, and PEX32), which are
organelles that play a role in metabolism, signaling, and ROS detoxification. The different ROS
levels and gene expression profiles of CdSe/ZnS and InP/ZnS-treated cells could be a
consequence of their unique physiochemical characteristics that affect their uptake and
trafficking [16]. However, results on QD toxicity can differ drastically due to different methods
of synthesizing QDs, and it is not uncommon for QDs from one batch to affect organisms
differently than the same QDs from a separate batch [118]. Future studies should characterize the
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cellular uptake mechanisms used by each type of QD, the rate of their degradation, and their
intracellular trafficking to better understand the associated cellular interactions and mechanisms
of toxicity.
Comparing Gene Expression Profiles of Yeast Exposed to CdSe/ZnS and InP/ZnS
QDs. I provide a model that depicts specific upregulated genes and potential physiological
changes induced by exposure to CdSe/ZnS QDs (Figure 22A). Of the upregulated genes, the
most serious seems to be those involved in transmembrane transport/cellular homeostasis,
vacuole acidification, amino acid metabolic activity, protein folding (Table 6), and cellular
trafficking (Table 5). In addition, several genes implicated in pre-RNA processing of ribosomal
subunits (SNR10, SNR17, SNR46, SNR49, SNR86, and NOP58), protein folding (KAR2 and
EUG1), and amino acid metabolism (ARG5, ARG6, ARO8, LYS1, LYS9, LEU1, LEU4, and
LEU9) were significantly upregulated. The upregulation of many genes implicated in protein
production could be in response to a high level of nonfunctional proteins that might have been
damaged by significantly increased superoxide levels [132, 133] resulting from CdSe/ZnS
exposure or CdSe/ZnS-protein interactions within the cells. I also noticed two upregulated genes,
YDR5 and YDR15, which are both ATP-binding cassette (ABC) transporters implicated in
yeast’s drug efflux [168, 169]. It is generally believed that these ABC transporters play an
important role in cellular detoxification and their upregulation suggests that yeast cells are
interpreting the presence of CdSe/ZnS QDs as a xenobiotic attack [168]. The upregulation of
genes involved in cellular detoxification could explain why CdSe/ZnS had no significant effect
on cellular growth (Figure 16A). However, we still do not fully understand the mechanisms
involved in shortening the lag phase of samples exposed to CdSe/ZnS (Figure 16G).
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The expression of genes implicated in endocytosis (ARP2, ARP3, GTS1, CLC1, BBC1,
BZZ1, SCD5, MYO3, and MYO5) and the ETC function (COX5A, COX5B, COX6, COX7, COX8,
COX9, COX10, COX11, COX12, COX14, and COX17) was significantly lowered in CdSe/ZnStreated samples (Figure 22B) [31,34,35]. Additionally, genes implicated in proteasome assembly
(ECM29 and PBA1) were downregulated, suggesting an unbalanced protein degradation and
production under unfavorable conditions or unbalanced ROS levels with these QDs. This idea is
consistent with the prior finding where the function of 26S proteasomes was crippled by the
oxidative stress caused by H2O2 [170]. Interestingly, I found the expression of genes implicated
in trans-Golgi network trafficking (SNX3, SNX4, MVP1, Vps21, Vps51, Vps52, and Vps53
implicated in transport between the endosome and Golgi) was downregulated in CdSe/ZnStreated cells and after further testing, I observed a defect in trafficking through an increased
number of Vps10-GFP puncta (Table 7) [16].
I also created a detailed model of the potential effects induced by InP/ZnS QDs (Figure
22C). InP/ZnS exposure upregulates approximately 3 times as many genes compared to
CdSe/ZnS-treated samples (Figure 23A). Significantly upregulated processes in InP/ZnS-treated
samples include endocytosis, peroxisome assembly, proteasome assembly/activity, the Cvt
pathway, the ETC, and oxide reduction metabolic processes (Table 6). Interestingly, I found the
downregulation of ETC genes to be unique to CdSe/ZnS-treated cells. An opposite effect on
ETC was observed in InP/ZnS-treated samples where ETC genes were significantly upregulated,
including AIM31, COX4, COX5B, COX6, COX7, COX9, COX12, COX13, and COX15 (Figure
22C). I also found many genes associated with endocytosis to be downregulated in CdSe/ZnStreated samples, but significantly up- and downregulated in InP/ZnS-treated samples.
Upregulated endocytosis genes included LSB6, SDB17, YAP1801, CHC1, and ACT1, while
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downregulated endocytosis genes consisted of MYO3, MYO5, ENT1, ARK1, and VRP1 (Table
8). Interestingly, after gene expression analysis, I found proteasome assembly to be a
downregulated process in CdSe/ZnS-treated samples (PBA1 and ECM29) and upregulated in
InP/ZnS-treated samples (ECM29, CDC34, CDC53, HRT3, and DIA2).
InP/ZnS significantly downregulates approximately half the number of genes when
compared to the number of downregulated genes from CdSe/ZnS-treated cells (Figure 23B).
DEGs that are depicted in Figure 21D are significantly downregulated processes including
endocytosis, rRNA processing, translation, the Cvt pathway, actin and microtubule growth,
vesicle fusion, and protein targeting to the plasma membrane, and trans-Golgi network
trafficking (Table 9). A gene encoding a microtubule plus-end tracking protein, BIK1, was
downregulated in InP/ZnS-treated samples. These proteins are known to play roles in key
cellular processes including cell motility, intracellular trafficking, and pathways that align the
mitotic spindle with the division axis of the cell, making them crucial in cell division [171].
Another important player implicated in cell division is a gene encoding a capping protein, CAP2.
In samples exposed to InP/ZnS, CAP2 was significantly downregulated. In yeast, single actin
monomers are used to synthesize actin cables involved in polarized growth, and in yeast lacking
CAP1 or CAP2 have low levels of free actin due to excessive F-actin assembly in cortical
patches, which is detrimental to the assembly on actin cables [172]. These genes, downregulated
in InP/ZnS-treated samples, might contribute to InP/ZnS QDs’ negative impact on proliferation
compared to CdSe/ZnS QDs. Additionally, I found noticeably fewer DEGs involved in
endocytosis, SNAREs, and the Retromer when treated with InP/ZnS (Table 5), which suggests
different uptake and trafficking mechanisms are at work compared to CdSe/ZnS-treated samples.
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Effects of CdSe/ZnS and InP/ZnS QDs on the Intracellular Trafficking of Vps10GFP. Cargo trafficking in yeast is primarily done by a complex endosomal system that sorts
lipids, proteins, and a variety of cargo. The system begins when cargo is endocytosed and
trafficked to the early endosome where it is sorted and either sent to the lysosome for
degradation or targeted to the Golgi or plasma membrane through a retrograde or recycling
pathway. Endosome-to-Golgi retrograde and Endosome-to-plasma membrane recycling
pathways orchestrate the re-use of sorting receptors and are important in creating the lysosome
and determines what is sent to compose the plasma membrane. These pathways are responsible
for many cellular functions including homeostasis and quality control of lipids and proteins.
Negatively impacting the endosomal sorting pathways have been linked to many diseases
including, but not limited to, cancer, Parkinson’s disease, and Alzheimer’s [173].
Vps10 is an integral sorting receptor protein that plays a role in the sorting of newly
synthesized carboxypeptidase A at the trans-Golgi and that shuttles back and forth between the
trans-Golgi and the endosome [173]. I treated yeast containing Vps10-GFP with the QDs and
observed alterations in the phenotypes compared to non-treated cells via confocal microscopy.
[16]. I found significant differences in the number of puncta in QD-treated cells. CdSe/ZnS QDs
significantly increased the number of puncta and InP/ZnS QDs significantly decreased the
number in yeast. [16], both of the QDs have the same carboxylic acid ligands on their surface.
Additionally, each QD possesses identical ZnS shells that surround their respective cores (CdSe
and InP). This suggests that differences in Vps10-GFP phenotypes are due to their different
physiochemical effects of CdSe and InP-cores. It is important to note that understanding the
cellular mechanisms that are coordinated by their different physiochemical properties is essential
in evaluating QD toxicity and is still poorly understood.
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Figure 22. Detailed schematic models representing changes in cellular processes with CdSe/ZnS
QDs or InP/ZnS QDs in the budding yeast. (A) CdSe/ZnS QD exposure causes an increase in the
expression of genes involved in cellular processes such as transmembrane transport/cellular
homeostasis, vacuole acidification, amino acid metabolic activity, protein folding, and trafficking
within the trans-Golgi network. (B) Decreased expression in many genes treated with CdSe/ZnS
has revealed many important downregulated processes involved in endocytosis, the Cvt pathway,
rRNA processing, proteasome assembly, metabolic activity, cell cycle regulation, and trafficking
within the trans-Golgi network. (C) Yeast exposed to InP/ZnS QDs has upregulated many genes
required for processes like endocytosis, peroxisome assembly, proteasome assembly and activity,
the Cvt pathway, the ETC, and oxido-reduction metabolic processes. (D) Several more processes
are downregulated when exposed to InP/ZnS QDs including endocytosis, rRNA processing,
translation, the Cvt pathway, actin and microtubule growth, vesicle fusion, and protein targeting
to the plasma membrane, and some trans-Golgi network trafficking.
Comparing the Biological Effects of CdSe/ZnS with Known Biological Effects of Cd
in Saccharomyces cerevisiae. Many types of metals and metalloids are widespread in nature and
can accumulate to high concentrations locally. These metals are not QDs but greatly affect
biological systems. Organisms have dealt with metals and evolved proteins that require metals
for catalytic functions and maintaining the correct structure [174]. On the other hand, some
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metals such as Cd interact and inhibit enzymes that disrupt normal cellular processes and
contribute to their toxicity, however, relatively little is known about their molecular mechanisms
of toxicity.

Table 6. CdSe/ZnS Induced DEGs Implicated in Upregulated Cellular Processes.
Upregulated GO-Terms
(CdSe/ZnS)
Transmembrane
transport/cellular
homeostasis

Genes in Figure 22A

YHK8, PDR5, and PDR15

Vacuole acidification

VMA2 and VMA16

Amino acid metabolic
activity

ARG5, ARO8, ARG6, LEU1, LEU4, LEU9, and
LYS1/9

Protein folding

KAR2 and EUG1

Trafficking within the
trans-Golgi network

VPS41 and SNX41

A table listing the GO-terms and genes in Figure 22A. It represents the multiple upregulated
cellular processes and genes in yeast exposed to 10 µg/mL CdSe/ZnS QDs. All genes
incorporated in this table exhibited expression levels significantly higher than expression levels
of NTC samples.
Using transcriptomic experiments and bioinformatics analysis, common metal-responsive
(CMR) genes have been identified. The transcriptome changes made when exposed to most
metals were analyzed and similar changes in gene regulation were observed, and make up the

Table 7. CdSe/ZnS Induced DEGs Implicated in Downregulated Cellular Processes.
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Downregulated GOTerms (CdSe/ZnS)Downregulated)

Endocytosis

The Cvt pathway

Genes in Figure 22B

MYO3, MYO5, CLC1, ARP2, ARP3, BZZ1, SCD5,
BBC1, and GTS1
ATG3, ATG4, ATG8, ATG12, ATG14, ATG15,
ATG16, ATG17, ATG19, ATG20, ATG23, ATG27,
ATG33, and ATG34

rRNA processing

MRM2, LAS1, UTP30, RPL9A, and KRR1

Proteasome assembly

PBA1 and ECM29

Metabolic activity

Cell cycle regulation

Cellular trafficking

ATP3, ATP4, ATP5, ATP7, ATP12, ATP14,
ATP15, ATP16, ATP18, ATP20, ATP22, MRP10,
MRP19, and MTF2
CDC4, CDC7, CDC14, CDC15, CDC20, CDC28,
CDC36, CDC37, CDC42, CDC45, CDC55,
CDC123, and SIT4
SNX3, SNX4, MVP1, VPS21, VPS51, VPS52, and
VPS53

A table listing the GO-terms and genes in Figure 22B. It represents the multiple downregulated
cellular processes and genes in yeast exposed to 10 µg/mL CdSe/ZnS QDs. All genes
incorporated in this table exhibited expression levels significantly lower than expression levels of
NTC samples.
CMR genes [174]. CMR genes were enriched with GO-terms of biological processes including
metal ion transport/homeostasis, ROS detoxification, carbohydrate metabolism, fatty acid
metabolism, and RNA polymerase II transcription [174]. The GO-term analysis of genes
differentially expressed by CdSe/ZnS QDs were not enriched with similar GO-terms, which
suggests that their transcriptomic profile is not similar to that of yeast exposed to Cd.
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Interestingly, the transcriptomic profile of cells treated with InP/ZnS had many similar GO-terms
to the CMR genes, which could suggest InP/ZnS QDs affect yeast very similarly to toxic metals
and metalloids.

Table 8. InP/ZnS Induced DEGs Implicated in Upregulated Cellular Processes.
Upregulated GO-Terms
(InP/ZnS)
Endocytosis

Genes in Figure 22C

Peroxisome assembly

PEX3, PEX5, PEX7, PEX15, PEX17, PEX18,
PEX19, PEX27, PEX29, and PEX32

Proteasome assembly and
activity

ECM29, CDC34/53, HRT3, and DIA2

The Cvt pathway

LSB6, SDB17, YAP1801, CHC1, and ACT1

ATG2, ATG4, ATG7, ATG8, ATG9, ATG10,
ATG11, ATG13, ATG14, ATG17, ATG20, ATG21,
ATG34, and VPS41

ETC

AIM31 and COX4, COX5B, COX6, COX7, COX9,
COX12, COX13, and COX15

Oxido-reduction
metabolic processes

GRX2

A table listing the GO-terms and genes in Figure 22C. It represents the multiple upregulated
cellular processes and genes in yeast exposed to 100 µg/mL InP/ZnS QDs. All genes
incorporated in this table exhibited expression levels significantly higher than expression levels
of NTC samples.
Cd metals specifically inhibit proteins that protect cells from oxidative stress including
glutathione and thioredoxins. When these enzymes are inhibited it results in an increase of ROS
levels due to a decrease in functional antioxidant genes [174]. The RNA-seq data revealed that
the CdSe/ZnS-treated group significantly downregulated two out of three thioredoxins (TRX1
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and TRX2). Alternatively, the InP/ZnS-treated group did not significantly change the expression
of any thioredoxin. These results suggest that CdSe/ZnS QDs and Cd metal have different
mechanisms of toxicity on yeast.

Table 9. InP/ZnS Induced DEGs Implicated in Downregulated Cellular Processes.
Downregulated GOTerms (InP/ZnS)

Genes in Figure 22D
MYO3, MYO5, ENT1, ARK1, and VRP1

Endocytosis
rRNA processing

RRB1, KRR1, RPL1B, and YUH1

Translation

PRT1 and TIF1

The Cvt pathway

VPS36

Actin and microtubule
growth

CAP2 and BIK1, respectively

Vesicle fusion and
protein targeting to the
plasma membrane
Cellular trafficking

SSO1, SNC2, and WSC4, respectively

SED5, VAM7, PEP12, VPS29, and VPS51

A table listing the GO-terms and genes in Figure 22D. It represents the multiple downregulated
cellular processes and genes in yeast exposed to 100 µg/mL InP/ZnS QDs. All genes
incorporated in this table exhibited expression levels significantly lower than expression levels of
NTC samples.
Conclusion
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In the present study, I provided evidence that CdSe/ZnS and InP/ZnS QDs have a mild
cytotoxic effect on yeast. In comparison, each QD appeared to exert unique cytotoxic effects in a
variety of tests. CdSe/ZnS QDs differentially regulated gene expression in a greater number of
genes, including all up and downregulated genes, than InP/ZnS QDs. Notably, InP/ZnS QDs
upregulated hundreds of more genes than CdSe/ZnS QDs. Interestingly, with another cytotoxic
experiment, I observed InP/ZnS QDs had a greater and dose-dependent effect on proliferation
whereas I observed no significant change in CdSe/ZnS-treated samples. As depicted in my
working models, I showed a significant downregulation in mitochondrial/ETC function and
genes implicated in trans-Golgi network trafficking in the presence of CdSe/ZnS QDs more so
than in InP/ZnS-treated samples. Additionally, the confocal microscopy analysis revealed

Figure 23. A proportionately accurate Venn-diagram that represents the number of up- and
downregulated genes whose expression has been significantly changed when exposed to
CdSe/ZnS QDs or InP/ZnS QDs. The overlapped segments of each Venn-diagram represent
genes that are differentially expressed when exposed to CdSe/ZnS and InP/ZnS QDs. The
portions of the Venn-diagram that do not overlap are up- or downregulated genes that become
differentially expressed only when exposed to CdSe/ZnS QDs or InP/ZnS QDs. (A) Every gene
whose expression was significantly increased when compared to the normal gene expression in
yeast cells when exposed to CdSe/ZnS or InP/ZnS QDs. (B) Every gene whose expression was
significantly decreased when exposed to CdSe/ZnS or InP/ZnS QDs.
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changes in Vps10-GFP trafficking in both QDs. It is generally believed that QDs, such as
CdSe/ZnS and InP/ZnS, are trafficked and processed differently due to their individual physiochemical properties. Based on my results, each QD induced dissimilar cytotoxic effects in the
experiments on the budding yeast. Currently, we understand little about the physiochemical
effects, and the mechanisms behind QD toxicity must be solved before they can be used in the
life sciences or medicine. It is essential, to our health and the environment, that the toxicity of all
QDs used, industrially or commercially, are thoroughly tested and understood in diverse cell
types and organismal models. The next steps in studying QD toxicity should include proteomic
analysis to identify novel protein interactions and better understand the effects on how their
physiochemical properties coordinate their toxicity.
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